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Adrenal, testis, and ovary are steroidogenic organs derived from a common primordium 
that consists of Steroidogenic factor 1 (SF1)-positive precursor cells. SF1 not only defines the 
steroidogenic lineages in these organs, but also controls their differentiation. In this thesis 
project, I used Sf1/Cre transgenic mice to generate different types of knockout models to study 
the development of Sf1-positive cells in mice. My study is specifically focused on (1) the 
contribution of adrenal capsular cells to the SF1-positive cortical cells; (2) the maintenance of 
SF1-positive cells; and (3) the interaction between SF1-positive adrenal cortical cells and 
adrenal medulla cells. Recent evidence implicates the Hedgehog (Hh) signaling pathway is 
involved in the appearance of steroidogenic cells in these organs. The Hh signaling pathway 
serves as a common crosstalk component and yet evolves diverse functions in the expansion 
and differentiation of the steroidogenic cells in a tissue-specific manner. In Chapter 2, I provided 
evidence showing that Sonic hedgehog (Shh) from adrenal cortical cells elicits its function on 
adrenal capsular cells, which contribute to the adrenal cortex population. Ablation of Shh in the 
differentiated cortical cells results in decreased proliferation of the undifferentiated capsular cells. 
Other than Hh signaling, microRNA machinery is also involved in the development of SF1-
positive cells. In Chapter 3, I demonstrated a tissue-specific requirement of Dicer1, the key 
enzyme for microRNA biosynthesis, among adrenal, testis and ovary. Adrenal cortical cells, 
Sertoli cells and Leydig cells show different sensitivity to the loss of Dicer1. Although Dicer1 was 
removed at the same time in these SF1-positive cells during development, these tissues 
underwent apoptosis at later different stages. In Chapter 4, the goal of this study was to 
investigate whether abnormal development of the adrenal cortex affects the differentiation of the 
adrenal medulla in mice. I used four mouse models with different types of defects in adrenal 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 THE DEVELOPMENT OF ADRENAL AND GONADS 
Adrenal and gonads (ovaries and testes) are the major sources of steroids essential for 
energy and salt homeostasis, immune functions, and reproduction. Adrenal and gonads share 
not only the ability to produce steroids, but also a common primordium when they first arise in 
embryos. In the mouse embryo at around 9.5 days post coitum or dpc, the adrenogonadal 
primordium forms as a result of proliferation of the coelomic epithelia that cover the urogenital 
ridge (1, 2). Cells in the adrenogonadal primordium become distinguishable from other somatic 
cells as a result of the expression of the orphan nuclear receptor Steroidogenic factor1 [Sf1, 
also known as Nr5a1, Ad4BP, or Ftzf1 (OMIM 184757)]. SF1 marks the steroidogenic 
precursors, which later become adrenal cortex and somatic cells in the future gonads (Fig. 1). 
SF1 is essential for formation of the adrenal and gonads and development of pituitary 
gonadotrophs and ventromedial hypothalamic neurons (1-4). Between 10-11 dpc via an 
unknown mechanism, the SF1-positive cells in the adrenogonadal primordium separate into two 
populations, which eventually differentiate into the adrenal primordium and gonadal primordium, 
respectively (Fig. 1).  
In the developing adrenal primordium, SF1-expressing cells serve as the foundation for the 
fetal adrenocortex (3). Linage tracing experiments suggest that the SF1-expressing fetal cortical 
cells also contribute to the adult adrenocortex (5). The adrenal primordium is later encapsulated 
by the mesenchymal capsular cells, which is thought to provide stem/progenitor cells in adult or 
regenerating adrenal (6, 7). In the absence of Sf1, the adrenal primordium forms initially but 
then degenerates via programmed cell death, leading to adrenal agenesis at birth (3, 8).  
Once separated from the adrenal primordium, the gonadal primordium undergoes dimorphic 
differentiation based on the genetic make-up of the embryos. In the XY embryo, a subset of the 
SF1-positive cells in the gonadal primordium starts to express the testis-determining gene Sry 
(Sex-determining region of the Y chromosome) and becomes Sertoli cells. SF1 participates in 
the establishment of Sertoli cell by regulating expression of Sry, Sox9, and anti-Müllerian 
 *This chapter is a revised version of the manuscript published in Mol Reprod Dev. (Huang CC, Yao 
HH. Diverse functions of Hedgehog signaling in formation and physiology of steroidogenic organs. Mol 
Reprod Dev. 2010 Jun;77(6):489-96.)  
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hormone (Amh) (9-11). Sertoli cells then produce paracrine factors that induce differentiation of 
SF1-positive/SRY-negative Leydig cells outside the testis cords (Fig. 1).  In the Leydig cells, 
SF1 controls the transcription of Insulin-like growth factor 3 or Insl3 as well as various enzymes 
involved in steroidogenesis (12-15). In male, testicular decent requires Leydig cell-derived Insl3 
(16-18).  
In the XX mouse embryo that lacks the Sry gene, transcription and translation of SF1 in the 
ovary decrease dramatically at 13.5 dpc right after when the male and female gonads become 
morphologically different. SF1 level remains low in the somatic cells of the fetal ovary but its 
expression rises again around birth at the onset of folliculogenesis (19). SF1 is critical for 
granulosa cell development as granulosa cell-specific SF1 knockout female lacks ovarian 
expression of SF1 target genes, resulting in decreased follicle numbers and infertility (20). 
 
1.2 COMPONENTS OF THE HH SIGNALING PATHWAY 
The Hh ligands are secreted proteins involved in many aspects of embryonic organ 
development and tumorogenesis in adult animals. In mammals, three Hh orthologs have been 
identified: Desert hedgehog (Dhh), Indian hedgehog (Ihh), and Sonic hedgehog (Shh). Although 
these three Hh genes have diverse expression patterns and functions, they are thought to 
induce a common signal transduction pathway in the target cells. Hh proteins bind to a receptor 
complex consisting of Patched family receptors (PTCH1 and PTCH2) and Smoothened (SMO) 
on the membrane. PTCH1 and PTCH2 have similar ligand binding affinity but their expression 
patterns are not fully overlapped (21). Hh-receiving cells are enriched with cilia where PTCH1 
receptors inhibit SMO activity by preventing its accumulation within cilia (22). Binding of Hh to 
PTCH1 releases the inhibitory effect of PTCH1 on SMO, therefore allowing SMO to activate the 
downstream signaling components that involves transcription factors GLI1, GLI2 and GLI3(23, 
24). In the absence of Hh, GLI2 and GLI3 are targeted for proteasomal processing (25-27). The 
processed GLI2 and GLI3 serve as repressors that inhibit target gene transcription. In the 
presence of Hh, activated SMO inhibits proteolysis of GLI2 and GLI3, leading to the production 
of full-length transcriptional activator forms of these proteins. GLI1, on the other hand, contains 
only the activation domain and acts solely as a transcriptional activator (28). Although Hh 
ligands probably act through a common pathway, they elicit different effects in the tissue-
specific manner, probably due to interaction with other signaling pathways (29).  
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1.3 THE THEORY OF PROGENITOR/STEM CELLS IN THE ADRENAL 
The adrenal capsule and the underlying subcapsular cells are postulated to be the sources 
of progenitor/stem cells for the adrenocortex (6). This concept is first raised from the result of 
cytological studies using the trypan blue dye. Trypan blue-labeled cells are restricted in the 
capsule right after the injection of the dye. Later on, the dye-labeled cells are found in the zona 
glomerulosa while the capsule becomes free of dye (30). In adult rats, when the adrenal 
parenchyma is removed (a process called enucleation), a functional cortex is restored within 30 
days, presumably due to regeneration of the remaining capsule and subcapsular cells (31, 32). 
Using 3H-thymidine pulse-chase to trace proliferating cells, it was found that cortical cells 
migrate centripetally from outer to inner layers (33, 34). An “escalator’ hypothesis was therefore 
proposed that the progenitor cells derived from the capsule migrate centripetally and become a 
part of adrenal cortex (35, 36). The centripetal movement also occurs in the differentiated 
adrenocortical cells, which are aligned in columns (37, 38).  
Recent observations suggest two possible sources of adrenocortical cells: 1) the SF1-
positive cells from the adrenal primordium, which forms the foundation of the organ and 2) SF1-
negative capsular cells, which contribute to further growth of the adrenocortex. The linage 
tracing experiment performed by the Morohashi group in Japan demonstrates that the adult 
adrenocortex could derive from not only the SF1-positive cells in the fetal adrenal, but also from 
unknown cell populations that are negative for SF1 (5). 
In the fetal mouse adrenal, Shh is present and its expression is restricted to the outer 
layer of adrenal cortex underneath the capsule. In addition to Shh, Gli3 is another gene in the 
Hh pathway that plays a role in adrenal development. Gli3 mutant mice display a wide range of 
developmental abnormalities including absence of adrenal glands (39). In humans, Pallister–Hall 
syndrome (PHS) represents autosomal dominant disorders associated with central polydactyly, 
imperforate anus, hypothalamic hamartoma and other malformations (40, 41). A mutation in the 
GLI3 gene that results in a truncated form of GLI3 protein is found in some human PHS patients 
with adrenal hypoplasia and kidney malformation (42). It remains to be determined whether Gli3 




1.4 HH SIGNALING IN THE FETAL TESTIS 
In fetal mouse testis, Sertoli cells start to produce Dhh at 11.5 dpc via a coordinate action of 
SF1 and DAX1, right after the onset of testis differentiation (43-45). The Hh receptor Ptch1 is 
expressed in the interstitial compartment 24 hrs after Dhh expression (45) and Gli1 and Gli2 
expression mirror the pattern of Ptch1 (unpublished results). The down regulation of Ptch1 in 
Dhh null mutants indicates that Dhh could be the primary Hh ligand in action in fetal testes (45). 
Inactivation of the Dhh gene in mouse with 129/Sv inbred background results in properly 
formed testes; however, these males are infertile with complete absence of mature sperms (45). 
Interestingly, when the Dhh null alleles are introduced to a mixed genetic background, severe 
testis dysgenesis phenotypes arise in the fetal testis, including apolar Sertoli cells and 
anastomotic testis cords (46, 47). In addition to testis cord dysgenesis, both Dhh knockout male 
mouse and human patients with DHH mutation exhibit male pseudohermaphroditism with 
underdevelopment of internal male accessory organs and feminized external genitalia due to 
insufficient production of androgens (48-50). It is later found that loss of Dhh leads to a 
decreased number of fetal Leydig cells, the major source of androgens (51). However, a few 
fetal Leydig cells remain in the Dhh knockout testis, suggesting that other pathways such as 
Pdgf could partially compensate for the loss of Dhh (52). When fetal testes are cultured ex vivo 
with a general Hh inhibitor cyclopamine before the appearance of fetal Leydig cells, no fetal 
Leydig cells are detected after cyclopamine treatment (51, 53). However, cyclopamine has no 
effects on fetal Leydig cells when they are already present in the testis (51, 53). To investigate 
whether the Hh pathway alone is sufficient to induce fetal Leydig cell differentiation, we activate 
the Hh pathway ectopically in the SF1-positive cells in the fetal ovary, where the Hh pathway is 
normally silent. Fully differentiated fetal Leydig cells appear in the fetal ovary in response to Hh 
activation. The ectopic fetal Leydig cells in the ovary are functional, producing enough 
testosterone that masculinize the female embryos (54). The effects of Hh activation on the 
transformation of SF1-positive cells to fetal Leydig cells in the ovary is direct, as evident by the 
absence of Sertoli cells and other testicular factors.  These results together indicate that (1) the 
Hh pathway is the primary facilitator of fetal Leydig differentiation and (2) the Hh pathway is 
responsible for initiation, rather than maintenance, of fetal Leydig cell differentiation.  
DHH triggers fetal Leydig cells differentiation by up-regulating Sf1 expression in the 
precursors of fetal Leydig cells (51, 55). Ectopic activation of the Hh pathway in the fetal ovary 
also induces expression of SF1 (54). In humans, SF1 haploinsufficiency is associated with 
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impaired Leydig cell function (56). Haploinsufficiency of Sf1 in mouse embryos causes delayed 
expression of both Sertoli and Leydig cell markers such as Amh, Cyp11a1 and Cyp17 (43). 
Loss of one Sf1 allele in the Dhh knockout background (Sf1+/-;Dhh-/-) abolished fetal Leydig cell 
population compared to the reduced fetal Leydig cell population in Sf1+/+;Dhh-/- males (15). 
Several conserved Hedgehog responsive elements (HRE, TGGGTGGTC) are present in the 
mouse Sf1 promoter region, suggesting a direct role of the Hh signaling on Sf1 transcriptional 
regulation.  
In summary, in the fetal testis, the SF1-positive precursor cells differentiate into at least two 
distinct somatic cell populations: DHH-producing Sertoli cells and DHH-responsive fetal Leydig 
cells. The main function of this paracrine crosstalk is to ensure proper appearance of fetal 
Leydig cells and production of androgens (Fig. 2). In addition to Dhh, we have found that Shh 
mRNA is also expressed in the developing testis. However, contrary to the Dhh knockout, mice 
that lack Shh specifically in the SF1-positive cells in the testis are fertile, indicating that Shh 
alone is dispensable for testis development (Appendix A). 
 
1.5 HH SIGNALING IN THE OVARY 
In the fetal mouse ovary, the Hh pathway is presumably inactive based on the fact that 
expression of Dhh, Ptch1, Gli1, and Gli2 is absent (44, 51). However, the Hh pathway appears 
to be activated in the adult mouse ovary. In situ hybridization results reveal the cellular sources 
of Dhh and Ihh in granulosa cells and Ptch1 and Gli1 in the adjacent theca cell compartment in 
mouse ovaries (57, 58). During preovulatory stages after superovulation induction, both Ptch1 
and Gli1 in the theca cell compartment are gradually decreased along with the loss of 
expression of Ihh and Dhh in granulosa cells (57). In vitro study shows that treatment of follicles 
with SHH increases proliferation of granulosa cells, while treatment with Hh inhibitor 
cyclopamine increases the progesterone production (58). Bovine theca cells express Ptch1 and 
Smo and treatment of SHH induce proliferation and androstenedione production in these cells in 
culture (59). These data indicate a possible paracrine crosstalk between granulosa (source of 
Hh) and theca cells (Hh-responding cells) in steroidogenesis and cell proliferation (Fig. 3). Dhh 
knockout female mice have no obvious phenotypes and are fertile (45). In addition, inactivation 
of Shh in the SF1-positive cells in the ovary yields no ovarian phenotypes (unpublished results). 
Although other Hh ligands may compensate for lack of Dhh or Shh in these cases, the exact 
role of the Hh pathway in ovarian development remains to be determined.  
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Expression of SHH, DHH, PTCH1, SMO and GLI1 proteins is increased stepwise in benign, 
borderline and malignant ovarian tumors (60, 61). Inhibition of the Hh pathway by cyclopamine 
or Gli1 siRNA results in decreased cell proliferation of ovarian carcinoma cells (60). In addition, 
ectopic activation of the Hh pathway in mouse granulosa cells leads to infertility, reduced 
ovulation and delayed luteinization (62). These observations indicate that aberrant activation of 
the Hh pathway may be responsible for ovarian abnormality and carcinogenesis.  
 
1.6 microRNA MACHINERY 
miRNAs, which are 19-25 nucleotides long, non-coding RNAs, regulate gene expression by 
binding to target mRNAs in a sequence-specific manner, subsequently inhibiting their translation 
or inducing their degradation (63-65). This post-transcriptional gene regulation machinery has 
been identified in controlling diverse aspects of development in variety of organisms from plants 
to mammals. The formation of miRNA requires RNA endonuclease named Dicer, which is 
encoded by Dicer1 in mouse. Dicer protein contains RNase III domains cleaves double strain 
RNA into 19-25 nucleotides long microRNAs. These microRNAs then bind with several different 
proteins and form a protein complex called RISC, the RNAi Silencing Complex. RISC first 
unwinds the miRNA duplex. Then the single stain miRNA coupled with RISC is able to bind 
mRNA and block its translation. In mice, general knockout (KO) of Dicer1 resulted in embryonic 
lethality around 7.5 dpc (66). Inability of Dicer1 KO embryonic stem cells to develop further 
highlights the role of miRNA machinery in maintaining stem cell population at early developing 
stages. Results from tissue-specific KO of Dicer1 gene in mice have demonstrated the 
importance of miRNAs in organogenesis including heart, lung, and limb (67-69). 
The shared origin of SF1-positive cells in adrenal and gonads raises the possibility that a 
common regulatory mechanism is present for the establishment or maintenance of these cell 
lineages. Importance of Dicer1 and miRNAs has been documented in the adult testis and ovary 
(70-73).  Loss of Dicer1 in Sertoli cells resulted in increased Sertoli cells and germ cells 
apoptosis, impaired spermatogenic waves and completely absence of spermatozoa (70). Loss 
of Dicer1 in granulosa cells resulted in decreased ovulation rate, trapped oocytes in luteinized 
follicles and increased numbers of atretic follicles (71, 74, 75). Due to the late expression of the 
Cre recombinase, these somatic cells Dicer1 KO models highlight the importance of 
Dicer1/miRNA at later developmental stages. However, how Dicer1/miRNA regulates the early 




 The Hh family of proteins is one of the highly conserved paracrine/autocrine morphogens 
that relates to developmental processes. In the developing adrenal and gonads, evidence of a 
paracrine crosstalk via the Hh pathway is emerging. The Hh ligands are produced by the 
earliest differentiated SF1-positive cells such as adrenocortical cells in the adrenal (Shh), Sertoli 
cells in the testis (Dhh), and granulosa cells in the ovary (Dhh and Ihh). DHH is the primary 
regulator that initiates fetal Leydig cell differentiation. In the adult ovary, multiple Hh ligands 
appear to be involved in steroidogenesis of the theca layer. It is interesting to note that most of 
the Hh-producing cells are SF1-positive and the Hh-receiving cells respond to the Hh ligand by 
upregulating SF1 expression. This suggests that Hh activation could be a universal mechanism 
for the induction of SF1 in certain cell lineages. In the field of the study of SF1-postive cells in 
the adrenal and the gonads, there are several questions need to be answered. First, for SF1-
positive cells development, more studies are needed to determine how certain cells in the 
adrenal and gonads acquire the ability to produce Hh and how a tissue-specific regulatory 
pattern is established. Furthermore, the role of the Hh pathway in adult adrenal and gonads 
require further investigation. Second, the role of miRNA in the SF1-postive cells is also unclear. 
The importance of Dicer1 and miRNAs has been documented in the adult testis and ovary (70-
73, 76). However, the function of Dicer1/miRNA during fetal or neonatal development of SF1-
positive cells is unknown. The shared origin of SF1-positive cells in adrenal and gonads raise 
the possibility that a common regulatory mechanism is present for the establishment or 
maintenance of these cell lineages. Third, one of the major functions of SF1-positive cells is 
steroidogenesis. In the adrenal, glucocorticoid has a local stimulatory action on the synthesis of 
medulla adrenaline. Besides, loss of SF1-postive cells results in loss of the entire adrenal at 
birth, including the medulla. The role of the cortex on medulla development is still unclear. To 
study these three unknown questions in the field of SF1-positive cells, I developed mouse 
genetic models in which the Hh pathway and Dicer pathway were altered in the SF1-positive 
cells. Phenotypes of these mouse models will provide information to the field of the study of 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CHAPTER 2: PROGENITOR CELL EXPANSION AND ORGAN SIZE OF MOUSE ADRENAL 
IS REGULATED BY SONIC HEDGEHOG 
2.1 ABSTRACT 
The adrenal capsule is postulated to harbor stem/progenitor cells, whose progenies contribute 
to the growth of adrenocortex. I discovered that cells in the adrenal capsule are positive for 
Ptch1 and Gli1, genes indicative of responsiveness to the stimulation of Hedgehog (Hh) ligands. 
On the other hand, Sonic hedgehog (Shh), one of the mammalian Hh ligands, is expressed in 
the adrenocortex underneath the adrenal capsule, suggesting crosstalk between the 
adrenocortex and the Hh-responding capsule. To investigate the functional significance of this 
crosstalk in adrenal growth, I ablated Shh in an adrenocortex-specific manner using the 
Steroidogenic factor 1-Cre (Sf1/Cre) mouse. Sf1/Cre induces targeted deletion of the floxed 
genes in the SF1-positive adrenocortical cells.   Loss of Shh in the adrenocortex led to reduced 
proliferation of capsular cells and a 50-75% reduction in adrenocortex thickness and adrenal 
size. The remaining adrenocortex underwent proper zonation and was able to synthesize 
steroids, indicating that Shh is dispensable for differentiation of adrenocortex. Using a genetic 
lineage-tracing model, I further demonstrated that that the Hh-responding cells in the adrenal 
capsule migrated centripetally into the adrenocortex. Once these capsular cells became a part 
of the adrenocortex, they turned off the Hh pathway and became refractory to Hh activation. My 
results not only provide the first genetic evidence to support that the adrenal capsule contributes 
to the growth of adrenocortex, but also identify a novel crosstalk between the adrenocortex and 






*This chapter is a revised version of the manuscript published in Endocrinology (Huang CC, Miyagawa S, 
Matsumaru D, Parker KL, Yao HH. Progenitor cell expansion and organ size of mouse adrenal is 




  Organogenesis requires a balance between cell proliferation and differentiation. 
Progenitor cells of the organ primordium undergo self-renewal and expansion while 
simultaneously differentiating into organ-specific cell types. In developing mouse adrenal, 
steroidogenic factor 1 (SF1)-expressing cells from the adrenogonadal primordium serve as the 
founders for the future cortex (3). The SF1-expressing primordium is later encapsulated by the 
mesenchymal capsule, which consists of a single coelomic epithelium and underlying layers of 
fibroblast-like cells (36). Cells in the adrenal capsule and subcapsular cortical region have a 
higher proliferation index (77). It is proposed that the progenies of these proliferating cells 
migrate centripetally and differentiate into adrenocortical cells (36, 78, 79). When the adrenal 
parenchyma is removed (a process called enucleation), the remaining capsule and subcapsular 
cells undergo regeneration, eventually leading to restoration of a functional cortex (31, 32). 
These observations together point to the possible existence of stem/progenitor cells in the 
adrenal capsule and subcapsular region.  
Establishment of the adrenal primordium and its growth are regulated by a network of 
transcription regulators. SF1, a putative orphan nuclear receptor, is expressed at as early as 9 
days post coitum or dpc in mouse adrenal cortex and the disruption of Sf1 causes adrenal 
aplasia (3). Dax1, which is also a member of the nuclear hormone receptor superfamily, 
represses SF1-mediated transcription and is specifically expressed in the highly proliferating 
cortical area (80-82). Loss of function of the Dax1 gene causes congenital adrenal hypoplasia in 
humans (83, 84). Other transcription factors such as transcription factor 21 (Tcf21, also known 
as Pod1), pre B-cell leukemia transcription factor 1 (Pbx1), Wilms tumor 1 (Wt1) and CBP/p300-
interacting transactivator with ED-rich tail 2 (Cited2) are also involved in adrenal development 
(85-88). The finding that Wnt4 and beta-catenin, a key component of the Wnt canonical 
signaling pathway, are essential for adrenal development (74, 89), implicates that the adrenal 
development is also under the influence of secreted signaling molecules. 
 SHH, a paracrine/autocrine morphogen, elicits its function by binding to the membrane-
bound complex consisting of receptor Patched1 (PTCH1) and Smoothened (SMO). Binding of 
SHH to PTCH1 releases the inhibitory effect of PTCH1 on SMO, therefore allowing SMO to 
activate the downstream signaling pathway that involves transcriptional regulation via Gli1, Gli2 
and Gli3 transcription factors (24). SHH is known to regulate expression of genes involved in 
cell proliferation (23) and plays critical roles in progenitor cell renewal, cell lineage specification, 
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and tissue regeneration in the organs of various species. For example, self-renewal of 
neurosphere-forming stem cells in adult mouse forebrain requires the presence of Shh (90). In 
mouse retina, SHH stimulates progenitor cell proliferation and diversification (91). SHH is also 
involved in differentiation of mouse and human embryonic stem cells (92, 93). Expression of 
Shh was found in the developing mouse adrenal (44)and Gli3 mutant mice developed adrenal 
agenesis (39), suggesting a critical role of the Hh signaling in adrenal development.  
 In this study, I tested the hypothesis that the adrenal capsule contributes to the growth 
and expansion of the adrenal gland. Using loss-of-function genetic model and a lineage-tracing 
experiment, I demonstrated that Shh is involved in the expansion of the progenitor pool in the 
adrenal capsule. SF1-positive adrenocortical cells control the expansion of the adrenocortex by 
producing SHH that acts upon the adrenal capsule.   
 
2.3 RESULTS 
2.3.1 Expression of Shh and its downstream signaling components in fetal adrenal 
To investigate whether Shh is involved in organogenesis of mouse adrenal, I first 
characterized the expression of Shh and its downstream signaling components (Gli1, Gli2 & 
Ptch1) using RT-PCR, in situ hybridization (Shh) and LacZ reporter lines (Gli1-LacZ and Ptch1-
LacZ).  At 14.5 days post coitum or dpc, RT-PCR results showed that mRNA for the Hh 
signaling components (Gli1, Gli2, Shh, and Ptch1) were present in the adrenal (Fig. 4A).  At this 
stage, when the adrenal primordium is encapsulated and has separated completely from the 
gonad, Shh mRNA was expressed in cell clusters in the adrenocortex immediately underneath 
the capsule (Fig. 4B). Most adrenocortical cells at this stage were positive for SF1 whereas the 
adrenal capsule was devoid of SF1 expression (Fig. 4C). The Hh downstream components (Gli1, 
Gli2 and Ptch1), on the other hand, were expressed exclusively in the adrenal capsule (Fig. 4D-
4F). Using double staining for Gli1-LacZ and SF1, I confirmed that the adrenal capsule, with the 
exception of the coelomic epithelium, was positive for Gli1-LacZ (Fig. 4G). The entire capsule 
including the coelomic epithelium was negative for SF1 (Fig. 4G). The specific expression 
pattern of Shh (in the cortex underneath the capsule) and its downstream molecules (in the 
capsule) prompts me to test whether the Gli1 in the capsule is under the control of Hh signaling. 
I first cultured the Gli1-LacZ adrenals in the presence of cyclopamine, an Hh antagonist. Gli1-
LacZ was significantly reduced in the capsule, indicating that the expression of Gli1 is sensitive 
to the Hh pathway (Fig. 4H).    
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2.3.2 Effects of Shh ablation in SF1-positive adrenocortical cells 
To identify the source of Shh and its functional roles in adrenal development, I ablated 
Shh specifically in the SF1-positive cells using Sf1/Cre transgenic mice (94). Expression of Shh 
in the adrenal was lost in the Shh conditional knockout embryos (or Sf1/Cre; Shh floxed/-, Fig. 5A) 
in comparison with the presence of Shh in the control genotypes (Sf1/Cre, or Shh floxed/+, or 
Sf1/Cre; Shh floxed/+; only Shhfloxed/+ is shown in Fig. 5B). These results indicate that the SF1-
positive cells are the major source of Shh in the adrenal. Expression of Gli1 was also down-
regulated in the Shh conditional knockout adrenal (Fig. 5C and D), further demonstrating that 
Shh is responsible for the activation of the Hh pathway in the adrenal.  
The effects of loss of Shh became evident at postpartum day 5 (P5) when the size of 
adrenals in the Shh conditional knockout animals was reduced to 25-50% of the size of the 
control littermates (Fig. 5E-H). The body weights of control and knockout animals were not 
different (control, 3.99±0.2g, n=9; KO, 3.61±0.1g, n=3). However, the thickness of the 
adrenocortex in the Shh knockout animals was significantly reduced (Fig. 5E & F). The reduced 
adrenal size could result from increased apoptosis, decreased cell proliferation, or both. I first 
performed the TUNEL assay and found few TUNEL-positive cells in the adrenal cortex or 
medulla and no differences between the control and Shh knockout mice at any stages analyzed 
(Fig. 5I & J and Fig. 6). This result excluded apoptosis as a cause for reduced adrenal size in 
the absence of Shh.  
I then assessed adrenal growth by triple immunofluorescent staining for the proliferation 
marker Ki-67, SF1, and DAPI nuclear dye (Fig. 7). At 14.5 dpc, numbers of Ki-67-positive cells 
in the adrenal were not affected by the loss of Shh (Fig. 7A, B, & G). However, at 16.5 and P5, a 
significant decrease in Ki-67–positive cell numbers was observed in the SF1-negative capsule 
in the Shh KO adrenal (Fig. 7C-F). The thickness of SF1-negative capsule was reduced from 4-
5 cell layers in the controls to 1-2 cell layers in the knockout (demarcated by white brackets in 
Fig. 7).  I obtained the percentage of Ki-67-positive cells in the capsule based on the total cell 
numbers (nuclear DAPI staining) and numbers of Ki-67-positive cells. SF1 staining was used to 
distinguish capsular cells (SF1-negative) and adrenocortical cells (SF1-positive). The 
percentage of proliferating cells in the SF1-negative capsule was significantly reduced in the 
Shh knockout adrenal at 16.5 dpc (Fig. 7G; control= 60% vs. knockout=40%, p<0.05) and P5 
(Fig. 7G; control= 30% vs. knockout=20%, p<0.05). These results demonstrate that Shh from 
the SF1-positive adrenocortical cells controls expansion of the adrenal capsule. Loss of Shh 
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and consequent decreased proliferation in the capsule leads to stunted growth of adrenal cortex, 
probably due to a diminishing supply of stem/precursor cells.  
 
2.3.3 Effects of Shh ablation in adrenal differentiation and steroidogenesis 
The decrease in size and proliferation in the Shh conditional knockout adrenal prompted 
me to examine whether the hypoplastic adrenal differentiates properly. Despite a reduction in 
size, the Shh conditional knockout adrenal expressed the cortex-specific enzymes 21-
hydroxylase (CYP21) and aldosterone synthase (CYP11b2) in a pattern similar to that of the 
control (Fig. 8A-D). In addition, the adrenal medulla differentiated properly based on the 
expression of medullar marker tyrosine hydroxylase (TH; Fig. 8E & F) and phenylethanolamine 
N-methyltransferase (PNMT; Fig. 8G-H). It is apparent that histological differentiation and 
zonation of the adrenal cortex and medulla does not require the presence of Shh.  
To further examine the steroidogenic ability of the Shh knockout adrenal, I measured the 
basal level of plasma corticosterone and found that it was similar in the control and Shh 
conditional knockout animals at 18.5 dpc and P5 (Fig. 8I). In contrast, a significant decrease in 
plasma corticosterone was observed in Shh conditional knockout animals under stress at P21 
(Fig. 8J, p<0.01). In spite of this defect, the Shh conditional knockout animals survived to 
adulthood without apparent systemic problems. 
 
2.3.4 Effects of Shh ablation in long-term adrenal growth 
 Adrenocorticotropic hormone (ACTH) is known as a pituitary-derived endocrine factor 
that stimulates adrenal cortical growth. Increased ACTH leads to adrenal hypertrophy and 
hyperplasia in adult animals. At P5, the level of proopiomelancortin (POMC, precursor of ACTH) 
mRNA in the pituitary was similar in the control and Shh conditional knockout mice (Fig. 9A), 
indicating that the thinner adrenal cortex does not due to pituitary defects. Mice with blunt stress 
response (low corticosterone level after stress) could have long-term ACTH overstimulation, 
leading to progressively larger adrenal upon aging (95). Shh conditional knockout mice not only 
had lower corticosterone level at P21 (Fig. 8J) but also a higher level of ACTH at the age of 1 
year (Fig. 9B). However, this elevated ACTH did not result in an increase in adrenal size in the 
Shh knockout animals, which the adrenal size was 20-30% of that of the control littermates. 
Cortical cells in the Shh conditional knockout adrenal underwent hypertrophy but their numbers 
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remain significantly lower than the control (Fig. 8C & D). The adrenocortical cells in the Shh 
knockout adrenal appeared to response to ACTH. However, loss of Shh abolished the 
proliferation in the capsule, leading to stunted growth of adrenal cortex even in adulthood. 
 
2.3.5 Contribution of Hh-responding cells in the adrenal capsule to the adrenal cortex 
 It is interesting to note that in the absence of Shh, the adrenocortex was underdeveloped 
(Fig. 5) although defects in proliferation were found in the capsule (Fig. 7). This observation led 
to the possibility that the progenies of the proliferating capsular cells eventually become a part 
of the adrenocortex. To test this possibility, I established a genetic fate-mapping system taking 
advantage of the exclusive expression of Gli1 in the adrenal capsule (Fig. 4D). I utilized the 
Gli1-CreERT2 model that expresses a tamoxifen-inducible Cre recombinase (CreERT2) in cells 
responding to Hh (96, 97). Temporal addition of tamoxifen defines the time point when Gli1-
expressing cells are marked, and all their progenies can then be traced by the presence of 
permanent LacZ reporter (98). I applied tamoxifen treatments to pregnant female carrying 
embryos with Gli1-CreERT2 and ROSA26 LacZ reporter genes at 14.5 and 15.5 dpc. Adrenals 
were harvested and stained for LacZ at 18.5 dpc, P1 or P5 (Fig. 10A). At 18.5 dpc, or 3 days 
after tamoxifen treatment, most LacZ staining was concentrated in the capsule and only a few 
LacZ-positive cells were found in the outer layer of the cortex immediately underneath the 
capsule (Fig. 10B & F). At P1, some clusters of LacZ-positive cells were found underneath the 
capsule (Fig. 10C & G). At P5, or ~9 days after tamoxifen treatment, clusters of LacZ-positive 
cells were found in the deeper part of the cortex, about 6-8 cell layers below the capsule (Fig. 
10D & H). The capsule remained LacZ-positive at P5, as was the case at 18.5 dpc and P1. No 
LacZ-positive cells were found in the adrenal of ROSA26 reporter and Gli1-CreERT2-negative 
animals after tamoxifen treatments (Fig. 10E & I). This finding demonstrates conclusively that 
Gli1-positive Hh-responding capsular cells migrate from the capsule and become parts of the 
adrenal cortex. 
 
2.3.6 Effects of ectopic activation of the Hh pathway in SF1-positive adrenocortical cells 
The Gli1-CreERT2 model marks the Gli1-expressing cells at the time of tamoxifen 
treatment (14.5-15.5 dpc), but not the endogenous expression of Gli1 at the time of tissue 
harvest (Fig. 10A). In the normal adrenal, the endogenous Gli1 expression was only found in the 
capsule, indicating that when these cells migrate into the cortex, they turn off the Hh pathway 
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(Fig. 4D). To examine the significance of this phenomenon, I designed a genetic model that the 
Hh pathway is ectopically activated in the SF1-positive adrenocortex. By crossing Sf1/Cre 
mouse to a transgenic mouse that carries a fusion protein containing yellow fluorescent protein 
(YFP) and a constitutively active form of Smoothened (SmoYFP) (99), I produced a situation that 
the Hh pathway is unrestricted activated in the presence of SF1-cre. In this particular model, the 
SF1-expressing cells became positive for SmoYFP and Gli1 expression was upregulated, 
indicating that the Hh pathway was ectopically activated (100). I obtained adrenals from these 
animals (Sf1/Cre; SmoYFP) and found that the adrenals of control and Sf1/Cre; SmoYFP animals 
were indistinguishable in size and structure (Fig. 11A-D). The expression of cortex enzyme 3 
beta-hydroxysteroid dehydrogenase (3βHSD), medulla marker TH, and the numbers of Ki-
67/SF1 double-positive cells were similar in both control and Sf1/Cre; SmoYFP adrenal at birth 
(Fig. 11A-D). These results suggest that once the Hh-responding capsular cells migrate into the 
adrenocortex, they turn off the Hh pathway and become refractory to Hh activation. 
 
2.4 DISCUSSION 
2.4.1 Shh derived from SF1-positive cortical cells stimulates cell proliferation in the 
adrenal capsule 
The hypoplastic adrenal capsule and underdeveloped adrenocortex in mice lacking Shh 
in the adrenocortex highlight the essential role of Shh in adrenal development. Acting as a 
paracrine factor, SHH derived from the SF1-positive adrenocortex stimulates the proliferation of 
the Hh-responding cells in the adrenal capsule. In the absence of Shh, cells in the adrenal 
capsule fail to expand and therefore produce fewer progeny that eventually differentiate into the 
adrenocortical cells. The generation of Sf1-Cre;Shh conditional knockout embryos enables us to 
not only identify the specific cell type that produces functional Shh, but also avoid the 
complications due to growth retardation and general failure of organ formation in the global Shh 
knockout. However, in addition to the adrenocortex, SF1-cre also targets cells in the anterior 
pituitary and other parts of the brain (94), raising the possibility that the impaired adrenal growth 
in the Shh conditional knockout animals could be secondary to pituitary defects. In collaboration 
with Dr. Lori Raetzman, we examined the anterior pituitary of the conditional knockout animals 
and observed no differences in their development compared to the controls (data not shown). 
Adrenocorticotropic hormone (ACTH), which is produced by the anterior pituitary, is known to 
stimulate proliferation of adrenocortical cells. Animals lacking ACTH production developed 
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adrenal abnormalities after P7 (101). The Shh conditional knockout animals showed reduced 
proliferation and stunted adrenal growth as early as at 16.5 dpc, much earlier than the onset of 
phenotypes in mice lacking ACTH. I therefore conclude that loss of Shh in the SF1-positive cells 
did not affect development of anterior pituitary and ACTH functions.  The primary cause of 
hypoplastic adrenal is the loss of adrenal Shh.  
 
2.4.2 Gli1-positive Hh-responding cells in the adrenal capsule are potential stem cells for 
the adrenocortex 
Gottschau in 1883 first described the histogenesis of adrenal, which laid the foundation 
for the “cell migration” theory that adrenocortical cells move centripetally from the capsule 
toward the medulla (78). Lineage-tracing experiments using trypan blue or BrdU pulse-chase 
further expand the notion that the adrenal capsule and its neighboring cells migrate inward and 
contribute to adrenocortex (79, 102). However, these experiments provided only circumstantial 
observations and alternative explanations such as incomplete penetration of the dye and BrdU 
were proposed. By using a fate-mapping system, I provided the first genetic evidence 
demonstrating that adrenal capsular cells migrate centripetally and become a part of 
adrenocortex. Moreover, I identified that the migration occurs at least in one specific cell 
population (Gli1-positive) that responds to SHH. Although our results strongly support that the 
Gli1-positive cell in the capsule are potential stem/progenitors of the adrenocortex, these results 
do not exclude other possible sources of stem/progenitor cells in the adrenal (103, 104). In 
addition to the adrenal capsule, others have proposed that each cortical zone (zona 
glomerulosa, zona fasciculata, and zona reticularis) contains its own stem/progenitor cell 
population that are able to differentiate into cells unique for the particular zone. An 
undifferentiated zone between the zona glomerulosa and zona fasciculata was also proposed to 
be the stem cell zone (104). The stunted adrenocortex and decreased in adrenal size in the Shh 
conditional knockout animals argue that adrenal capsular cells are a major source of stem cells. 
These stem cells constantly replenish the adrenocortical cell populations. If indeed other stem 
cells are present in the adrenocortex, these cells are not sufficient to compensate for the loss of 
stem cells in the adrenal capsule in the Shh conditional knockout adrenal.  
 
2.4.3 Migration of capsular cells into the adrenocortex involves a transition from Hh-
responsive to Hh-refractory stage 
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The putative stem cells in the adrenal capsule are positive for Gli1 and negative for SF1. 
When the progenies of the Gli1-positive/SF1-negative capsular cells migrate into the adrenal, 
they lose Gli1 expression and gain the characteristics of the adrenocortex such as SF1 
expression (Fig. 10J). I designed a genetic model that the Hh pathway is ectopically activated in 
SF1-positive adrenocortical cells, testing the possibility whether activation of Hh is able to 
reverse the differentiated stage to stem cell stage of these cells. I found that the SF1-positive 
adrenocortical cells are incapable of responding to the ectopic activation of the Hh pathway. I 
speculate that the transition from Gli1-positive/SF1-negative to Gli1-negative/SF1-positive is a 
shift of cell identify from stem cells (Hh-responsive) to differentiated cells (Hh-refractory). When 
these Hh-responding capsular cells enter the differentiation program in the adrenocortex, they 
loss the progenitor properties to respond to SHH. It remains to be determined whether this 
transition from Hh-responsive to Hh-refractory is regulated by external signals or by intrinsic 
programming of the stem cells. 
 
2.4.4 Shh is not required for differentiation of adrenal cortex and medulla  
Although Shh is required for expansion of adrenal capsule and cortex, it is not essential 
for the zonation and differentiation of the adrenal. Expression of markers for the cortex and 
medulla was not affected by the loss of Shh. Expression of PNMT in the medulla requires a high 
level of glucocorticoids (105). Decreased PNMT expression was observed in mice deficient in 
glucocorticoid production or signaling, such as the Cyp21 knockout, CRHR1 knockout, SF1 
heterozygous, and glucocorticoids receptor knockout mice (106-109). The presence of PNMT in 
the Shh conditional knockout adrenal suggests that the hypoplastic cortex in the Shh knockout 
animals is still able to synthesize sufficient glucocorticoids to maintain the differentiation of the 
adrenal medulla. This notion is further supported by the observation that the basal level of 
plasma corticosterone was similar in control and Shh conditional knockout animals at 18.5 dpc 
and P5. This was not unexpected due to the fact that at 18.5 dpc, maternal-derived 
corticosterone is the major source of gucocorticoids in fetal blood (110). At P5, corticosterone is 
maintained at a basal level and the hypothalamic-pituitary-adrenal (HPA) axis is hyposensitive 
to most stresses (111, 112). The well-defined zona glomerulosa and zona fasciculata indicate 
that Shh is not involved in zonation of the adrenocortex. However, fewer cells in the Shh 
knockout cortex were unable to produce adequate corticosterone in response to an acute 
demand such as stress. 
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In summary, I provided the first genetic evidence demonstrating the significance of the 
adrenal capsule in adrenocortex expansion via the signaling of SHH. Through a unique 
interaction between the SF1-positive cortical cells and SF1-negative capsular cells, SHH 
stimulates proliferation of progenitor cells in the adrenal capsule. The Hh-responding capsular 
cells then migrate inward and contribute to the adrenocortex. Findings of this research provide 
not only an understanding of how a precursor cell population is regulated during organogenesis, 
but also potential applications for development of stem cell therapy for treatment of adrenal 
insufficiency.  
*Note: As a result of the SF1-cre activity, Shh was also depleted in the somatic cells of the 
gonads. The result of gonadal phenotypes is listed in Appendix A.  
 
2.5 MATERIALS AND METHODS 
2.5.1 Animals and the experimental protocols 
The Ptch1-LacZ reporter line and the Shh floxed mice were purchased from the Jackson 
Laboratory (Bar Harbor, ME) and the Gli1-LacZ mice were provided by Dr. Alexandra Joyner 
(113, 114). I first generated the Shh+/- mice by crossing the Shhf/f male mice to EIIa-Cre female 
mice, which express the Cre recombinase ubiquitously since the one-cell stage (115). Then the 
EIIa-Cre was removed by backcrossing to inbred strain (C57BL/6) female. The resulting Shh+/- 
mice were mated with Sf-1/Cre transgenic mice (94) to obtain the Shh+/-;Sf-1/Cre mouse line. 
Conditional Shh knockout mice were then generated by mating Shh+/-;Sf-1/Cre with Shhf/f mice. 
Female and male mice were paired together and checked for the presence of a vaginal plug the 
next morning. The day when the vaginal plug was detected was considered 0.5 days of 
gestation, or 0.5 dpc. All procedures described were reviewed and approved by the Institutional 
Animal Care and Use Committee at University of Illinois and were performed in accordance with 
the Guiding Principles for the Care and Use of Laboratory Animals. All experiments were 
performed on at least three animals for each genotype.  
 
2.5.2 In vitro organ culture 
Samples were collected from 14.5 dpc Gli1-LacZ mice and cultured in DMEM culture 
medium with/without Cyclopamine for 48 hours (Cyclopamine stock solution: 2mg/ml DMSO, 




2.5.3 Histological Analysis, LacZ staining, and TUNEL assay 
The specimens were fixed with 4% paraformaldehyde/phosphate-buffered saline (PBS: 
137 mM NaCl,  2.7 mM KCl, 4.3 mM Na2HPO4 and 1.47 mM KH2PO4) overnight, and embedded 
in paraffin following standard sectioning and stain in hematoxylin/eosin. For LacZ staining, fresh 
tissues were prefixed in 4% paraformaldehyde/PBS for 30 minutes, followed by three washes in 
PBS. The tissues were stained in LacZ staining solution as described (116). For further 
immunohistochemical staining, tissues after LacZ staining were fixed and embedded in paraffin 
following standard sectioning procedure. TUNEL assay was performed on paraffin sections with 
Roche’s TUNEL assay kit (Roche Co., Ltd., Indianapolis, IN) according to the manufacturer’s 
instructions. 
 
2.5.4 Reverse transcription-PCR and quantitative real-time PCR (Q-PCR)  
 Total RNA was isolated from 18.5 dpc mice tissues or P5 mice pituitary using the TRIzol 
reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The 
reverse transcription was performed with total RNA and Omniscript RT kits (QIAGEN, Valencia, 
CA, USA) with random primers (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's 
instructions. For reverse transcription-PCR, first-strand cDNA (5 ng) was used as the template 
together with 500 nM of each primer in a MyCycler Thermal Cycler (Bio-Rad, Hercules, CA, 
USA) with MangoMix PCR mixture (Bioline, Taunton, MA, USA). For Q-PCR, first-strand cDNA 
(5 ng) was used as the template together with 250 nM of each primer in a MJ Research PTC-
200 (Bio-Rad, Hercules, CA, USA) with DyNAmo SYBR green qPCR kits (Finnzymes, Valencia, 
CA, USA) to follow the progress of DNA synthesis. Primers used were 
GTGTTTCCTGGCAACGGAGATG (forward) and CATGAAGCCACCGTAACGCTTG (reverse) 
for Pomc. RNA amounts were calculated with relative standard curves and normalized by 36b4. 
 
2.5.5 Immunohistochemistry 
For immunohistochemical analysis, paraffin embedded sections (regular samples or 
samples after lacZ staining) were dewaxed and rehydrated in a series of alcohol to PBS. The 
endogenous peroxidase activity was blocked by 3% H2O2 in methanol for 8 minutes and rinsed 
with PBS 3 times for 5 minutes each. Slides were pretreated in 0.1mM citrate acid for 20 
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minutes in the microwave. After preincubating with 1.5% normal donkey serum in PBS for 30 
minutes, sections were incubated with either anti-SF1, anti-CYP21 (1:1000, kindly provided by 
Dr. B-c Chung, Academia Sinica, Taiwan), anti- CYP11b2 (1:1, kindly provided by Dr. C. 
Gomez-Sanchez, University of Mississippi Medical Center, Mississippi), anti-PNMT, anti-TH 
(1:1000, Millipore, Billerica, MA), anti-3βHSD  (1:1000, kindly provided by Dr. K. Morohashi, 
National Institutes of Natural Sciences, Japan.) or anti-Ki-67 antibody (1:1000, BD Biosciences, 
San Jose, CA) in PBST containing 1.5% normal donkey serum at 4℃ overnight. After rinsing 
with PBST, sections were incubated with secondary antibody for 30 minutes and processed for 
signal detection according to the manufacturer’s protocol. (TSA kit, PerkinElmer, Waltham, MA 
or ABC kit, Vector, Burlingame, CA). For double-fluorescent staining, two different primary 
antibodies produced by different species were mixed and applied, followed by appropriate 
secondary antibodies. The total cell numbers in the capsule were obtained by counting the 
numbers of nuclei stained with DAPI. The numbers of proliferating cells were obtained by 
counting nuclei positive for Ki-67 and DAPI. For each genotype, 3 sections that were 5 μm apart 
were counted and at least three animals were counted for each genotype.  
 
2.5.6 Hormone assays 
Plasma was collected from 18.5 dpc or P5 mice that were sacrificed by decapitation. For 
stressed group, mice at the age of P21 were exposed to carbon dioxide until they stopped 
breathing (~2 min), followed by cervical dislocation. Blood was collected by cardiac puncture. 
Plasma was collected in ice-cold EDTA rinsed tubes. Hormonal analyses were performed using 
EIA kits for corticosterone (Assay Designs, Ann Arbor, MI; sensitivity 26.99 pg/ml) according to 
the manufacturer’s instructions.  
 
2.5.7 Whole mount in situ hybridization 
Tissues were fixed overnight in 4% paraformaldehyde in PBS at 4°C. Then tissues were 
dehydrated through a methanol gradient in PBST (0.1% Tween20 in DEPC-PBS) to 100% 
methanol and stored at -20°C. Samples were rehydrated though a methanol/PBST gradient and 
digested in 10 μg/ml Proteinase K at 37°C for 12 minutes followed by immediate fixation in mix 
of 4% paraformaldehyde and 0.1% gluteraldehyde for 20 minutes. Samples were washed three 
times for 5 minutes each in PBST, followed by PBST/hybridization buffer (1:1) and hybridization 
buffer (Saline Sodium Citrate [0.75M NaCl, 75mM Sodium Citrate, pH5], 50% formamide, 0.1% 
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CHAPS, 0.1% Tween20, 1mg/ml Yeast tRNA, 50 ng/ml Heparin, and 5mM EDTA pH 8). 
Samples were incubated in a hybridization buffer 1 hour at 65°C. Then dioxigenin labeled RNA 
probe (1ng/ul hybridization buffer) was added, incubated at 65°C for 12-16 hours. Samples were 
washed with 65°C hybridization buffer twice (30 minutes each), followed by MABTL (5% MAB, 
0.1% Tween20 and 0.05% Levamisol) at room temperature. Samples were then incubated in 
20% heat-inactivated sheep serum in MABTL blocking (20 mg/ml Boehringer blocking powder) 
for 2-4 hours prior to the addition of alkaline phosphatase conjugated anti-dioxigenin antibody, 
1:1000 (Roche Diagnostics, USA). Samples were incubated at 4°C overnight on a shaker. Then 
samples were washed with MABTL 3 times (1 hour each). 20 μl/ml alkaline phosphatase 
substrate (NBT/BCIP, Roche Diagnostics, USA) in NTMTL (5M NaCl + 1M tris-HCl pH9.5 + 1M 
MgCl2 + 10% tween20 + 0.2g/ml Levamisol in DEPC H2O) was added for color development. 
The reaction was stopped at appropriate color intensity by washing in PBS and post-fixation in 
4% paraformaldehyde for 20 minutes at RT. The hybridization temperature of the Shh (kindly 
provided by Dr. Gen Yamada) and Gli1 (kindly provided by Dr. Alexandra Joyner) probes was 
65°C. 
 
2.5.8 Fate-mapping Analysis of Gli1-Positive Cells in Fetal Adrenal 
 Fate-mapping analyses were conducted by analyzing Gli1-CreERT2;ROSA26 mice (96, 
97). The Gli1-CreERT2 mice were crossed with ROSA26-LacZ reporter mice (117) to generate 
Gli1-CreERT2/+;ROSA26/ROSA26 males, which were subsequently used to impregnate ICR 
females. A 20 mg/ml stock solution of tamoxifen (T-5648, Sigma) was prepared in corn oil. One 
milligrams of tamoxifen per 10 g body weight was administered to the pregnant ICR mouse 
females using oral gavage at 14.5 and 15.5 dpc. The embryos were collected at 18.5 dpc and 
P5 and were processed for whole-mount X-gal staining. No overt teratologic effects were 
observed after tamoxifen administration under these conditions (98).  
 
2.5.9 Statistical Analysis 








Figure 4: Expression of Shh and signaling components of the Hh pathway in 14.5 dpc fetal 
adrenals. (A) RT-PCR for components of the Hh pathway (Gli1, Gli2, Shh, and Ptch1), (B) in situ 
hybridization for Shh, and (C) immunohistochemistry for SF1 were performed on wild type 
adrenals. Positive signals were blue in B and red in C. Black bracket in C demarcates the 
adrenal capsule, which is negative for SF1. (D-F) LacZ staining on sections from Gli1-LacZ, 
Gli2-LacZ and Ptch1-LacZ reporter adrenal and (G) double staining for SF1 (red) and LacZ 
(blue) were performed. Black arrowheads in G indicated the coelomic epithelium. (H) in vitro 
organ culture of testis, kidney, and adrenal from Gli1-LacZ reporter embryos with (right) or 




Figure 5: Effects of Shh ablation in adrenal morphology and apoptosis. Whole mount in situ 
hybridization for Shh (A & B) and Gli1 (C & D) were performed on control (Shh f/+) and Shh 
conditional knockout (Sf1-Cre; Shh f/-) 14.5 dpc embryos, respectively. (E & F) Whole-mount 
light field microscopic images of the urogenital system from control and Shh conditional 
knockout animals at P5.  White and red arrows indicate gonad and adrenal, respectively. (G & H) 
H&E staining for adrenal histology. (I & J) Adrenal sections after TUNEL assay for apoptosis. 
Green nuclear staining represented positive signals for fragmented DNA and blue staining was 
the DAPI nuclear counterstain. Images in the inlets were higher magnification of images in I and 





Figure 6: TUNEL assays on control and Shh conditional knockout adrenal sections at 14.5 (A & 
B), 16.5 (C & D), P21 (E & F), and 30 weeks (G & H). 16.5 dpc fetal ovaries as TUNEL-positive 
tissues (I & J). TUNEL-positive cells were labeled green with blue nuclear DAPI counterstain. 





Figure 7: Effects of Shh ablation on adrenal cell proliferation at 14.5 dpc (A & B), 16.5 dpc (C & 
D), and P5 (E & F). Triple immunofluorescence for Ki-67 (green), SF1 (magenta), and DAPI 
(blue) was performed on adrenal sections. White brackets outline the adrenal capsule, which 
was negative for SF1. (G) Percentage of Ki-67-positive proliferating cells in SF1-negative 
adrenal capsule at different stages. Black and white bars represent control (CT) and Shh 
conditional knockout (KO), respectively (P<0.05 versus control littermates). Scale bars 




Figure 8: Effects of Shh ablation on adrenal differentiation and zonation. Immunohistochemistry 
for CYP21(brown staining in A & B), CYP11B2 (red staining in C & D), TH (red staining in E & F), 
and PNMT (light red staining in G & H) were performed on adrenal sections from control and 
Shh conditional knockout at P5. (I & J) Corticosterone levels in plasma (ng/ml) measured by EIA 
at 18.5 dpc and P5 in (I) and P21 under stress in (J). Black and white bars represent control (CT) 
and Shh conditional knockout (KO), respectively (P<0.01 versus control littermates; 18.5 dpc: 






Figure 9: Effects of Shh ablation on pituitary function and adrenal physiology. (A) Pituitary 
Pomc mRNA level was measured by Q-PCR at P5 (CT, n=5, KO, n=3). (B) Basal ACTH levels 
in plasma (pg/ml) in 1-year old mice was measured by ELISA (P<0.01 versus control littermates; 
CT, n=8, KO, n=4). (C & D) Double-fluorescent immunohistochemistry for 3βHSD (magenta) 
and TH (green) was performed on adrenal sections from one-year old control and Shh KO mice 
with DAPI nuclear counterstain (blue). Higher magnification of the adrenocortex was shown in 




Figure 10: Fate-mapping experiment for Gli1-positive capsular cells. (A) Tamoxifen treatments 
were given to the pregnant female carrying Gli1-CreERT2;ROSA26 (B-H)or ROSA26 embryos 
(E & I) at 14.5 and 15.5 dpc. Adrenals were harvested and stained for LacZ (blue) at either 18.5 
dpc (B & F), at birth (C & G) or P5 (D & F, E & I). (J) The model of Shh signaling in adrenal 











Figure 11: Differentiation and proliferation of the adrenal in control and Sf1/Cre; SmoYFP animals 
at birth. (A & B) Double fluorescent immunohistochemistry for 3βHSD (magenta) and TH (green). 
(C & D) Double fluorescent immunohistochemistry for SF1 (magenta) and Ki-67 (green). Scale 





CHAPTER 3: INACTIVATION OF Dicer1 IN STEROIDOGENIC FACTOR 1-POSITIVE CELLS 




The synthesis of micorRNA (miRNA) is a multi-step process that requires the action of 
ribonuclease Dicer1. Dicer1 is responsible for the final processing of miRNA and has been 
implicated in cellular processes such as proliferation, apoptosis, and differentiation. Mouse 
embryos lacking Dicer1 die in early embryogenesis. In this study, I investigated whether Dicer1 
is required for development of adrenal, testis, and ovary in mouse embryos. To target Dicer1 
deletion specifically in developing adrenals and gonads, I used Steroidogenic factor 1-cre 
(SF1/Cre) line that the Cre recombinase is active in the progenitor cells of adrenals and gonads. 
Lack of Dicer1 in the SF1-positive cells did not affect formation and early differentiation of the 
adrenals and gonads. However, increasing numbers of apoptotic cells were first detected in the 
Dicer1 knockout adrenal cortex at 18.5 day post coitum (dpc), followed by somatic cells and 
germ cells in the testis at postnatal day 0. Affected adrenal and testes underwent complete 
degeneration 48 hrs after the onset of apoptosis. However, ovaries were not affected at least 
until postnatal day 5, when the animals died due to adrenal insufficiency. I conclude that Dicer1 
is dispensable for formation and differentiation of fetal tissues derived from SF1-positive 
adrenogonadal primordium. Dicer1 is essential for maintaining cell survival in adrenal and testis; 
however, development of the ovary from fetal stages to postnatal day 5 does not require the 
presence of Dicer 1. My results reveal a tissue-specific requirement of Dicer 1 and microRNAs. 





*This chapter is a revised version of the manuscript published in BMC Developmental Biology. (Huang 
CC, Yao HH. Inactivation of Dicer1 in Steroidogenic factor 1-positive cells reveals tissue-specific 




Dicer1 gene encodes a protein containing RNase III domains essential for miRNA 
biogenesis. miRNAs, which are 19-25 nucleotides long, non-coding RNAs, regulate gene 
expression by binding to target mRNAs in a sequence-specific manner, subsequently inhibiting 
their translation or inducing their degradation (63-65). This post-transcriptional gene regulation 
machinery has been implicated in controlling diverse aspects of development in organisms from 
plants to mammals. In mice, general knockout (KO) of Dicer1 resulted in embryonic lethality 
around 7.5 dpc (66). Inability of Dicer1 KO embryonic stem cells to develop further highlights the 
role of miRNA machinery in maintaining stem cell population at early developing stages. Results 
from tissue-specific KO of Dicer1 gene in mice have demonstrated the importance of miRNAs in 
organogenesis including heart, lung, limb and gonads (67-70, 72, 73, 76). 
Adrenal, testis, and ovary derive from a common primordium when they first arise in 
embryos. In the mouse embryo around 9.5 dpc, cells in the adrenogonadal primordium start to 
express the orphan nuclear receptor Sf1 [also known as Nr5a1, Ad4BP, or Ftzf1 (OMIM 
184757)] (19). Between 10-11 dpc, the adrenogonadal primordium divides into adrenal 
primordium and gonadal primordium (3, 118). The SF1-positive cells eventually differentiate into 
the cortical cells of the adrenal, Sertoli and Leydig cells in the testis, and granulosa and theca 
cells in the ovary. 
The shared origin of SF1-positive cells in adrenal and gonads raise the possibility that a 
common regulatory mechanism is present for the establishment or maintenance of these cell 
lineages. Importance of Dicer1 and miRNAs has been documented in the adult testis and ovary 
(70-73, 76). In this study, I developed a mouse model that Dicer1 gene was inactivated 
specifically in the SF1-positive cells in the adrenogonadal primordium, allowing me to study the 
overall functions of Dicer1 and miRNAs in the development of adrenal, testis and ovary. 
 
3.3 RESULTS 
3.3.1 Ablation of Dicer1 in SF1-positive cells causes prenatal degeneration of the adrenal 
cortex 
To investigate the functions of Dicer1 in development of adrenals and gonads, I generated 
a conditional knockout model that Dicer1 alleles were specifically inactivated in the SF1-positive 
cells, the precursors for cortical cells in the adrenals and somatic cells in the gonads (94). The 
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Dicer1-floxed allele has been shown to be a null allele upon Cre recombination in lung, limb, 
inner ear and germ cells (67, 68, 72, 119). The Sf1/Cre mouse line expresses high level of Cre 
recombinase in the adrenogonadal primordium at 10 dpc (94). I and others have used this 
Sf1/Cre line to delete or activate genes in the adrenogonadal primordium and observed adrenal 
and gonadal phenotypes at as early as 12.5 dpc (54, 74, 120).  
Among the three organs (adrenal, testis, and ovary) that derive from the SF1-positive 
adrenogonadal primordium, the adrenal was the first to show histological/morphological 
phenotypes in response to the loss of Dicer1. The Dicer1 conditional knockout (or KO, Sf1/Cre; 
Dicer1 floxed/floxed) adrenals were indistinguishable from the control adrenal (or CT, Dicer1 
floxed/floxed or Dicer1 floxed/+) up to 16.5 dpc. At 18.5 dpc, the Dicer1 KO adrenals were significantly 
smaller than the control and the decrease in size continued thereafter (Fig. 12A). At P5, the size 
of KO adrenals was only 20%~30% of the control (Fig. 12A). The decreased adrenal size was 
not the result of general growth retardation based on the fact that the body weights of control 
and KO animals were not different (CT, 4.02±0.9g, n=27; KO, 3.52±0.9g, n=6; p=0.2). 
Immunofluorescence for markers for adrenal cortex (SF1) and medulla (tyrosine hydroxylase or 
TH) showed that the differentiation of cortex and medulla occurred properly in the KO adrenal 
compared to the control at 16.5 dpc (Fig. 12B). However as the adrenal development 
progressed, SF1-positive cells in the cortex were decreased in numbers and were almost 
completely absent at P5 (Fig. 12B). The growth of medulla was not affected in the KO adrenal 
over time and as a result of loss of adrenal cortex, the medulla in the KO adrenal was in direct 
contact with the adrenal capsule at P5 (Fig. 12B).  
To further examine the functions of the diminishing KO adrenal cortex, I analyzed the 
expression of steroidogenic enzyme 3β-hydroxysteroid dehydrogenase (HSD3b) by 
immunofluorescence. Similar to the SF1 results in Fig. 12B, the numbers of steroidogenic 
cortical cells were decreased at 18.5 dpc and these cells almost completely disappeared at P5 
(Fig. 12C). To investigate whether the loss of cortical cells results from increased cell death or 
reduced cell proliferation, I examined proliferation by staining for proliferation marker Ki67 and 
apoptosis by TUNEL assay. I found no apparent changes in the numbers of Ki67-positive cells 
in the KO cortex compared to the control (Fig. 12C). Using the TUNEL assay to access 
apoptosis, I observed an increase of TUNEL- and steroidogenic enzyme 21-hydroxylase 
(CYP21)-double positive cells in the KO adrenal cortex starting at 14.5 dpc (Fig. 13). In the 
control adrenal, only few TUNEL-positive cells in the cortex were observed during development 
(0-2 cells per section). However in the KO cortex, significant increase in TUNEL-positive cells 
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was observed at all time points (Fig. 13, average of 25 cells per section). At P5, only few 
apoptotic cells remained in the KO adrenal where almost all cortical cells were lost at this stage. 
As a result of loss of adrenal cortex, none of the Dicer1 KO animals survived beyond P5.  
 
3.3.2 Ablation of Dicer1 in the SF1-positive cells causes testis degeneration after birth 
Ablation of Dicer1 mediated by Sf1/Cre inactivates Dicer1 not only in the adrenal but also 
in the somatic cells of fetal testes and ovaries. Although Sf1/Cre was activated in the 
adrenogonadal primordium, the KO testis did not show any abnormality during fetal life. Sertoli 
cell differentiation and testis cord formation in the fetal testes were comparable between control 
and KO as indicated by SOX9 staining (Fig. 14). At the time of birth or P0, no morphological 
differences were found in the KO testis and epididymis (Fig. 15A and B). At P2 and P5, the size 
of the KO testis remained similar to that at P0 while the size of the control testis doubled (Fig. 
15A). Testis cords, as outlined by staining for laminin, started to degenerate at P2 in the KO 
testis and by P5, only few testis cords were observed (Fig. 15B).  
To investigate how loss of Dicer1 in the SF1-positive cells affects differentiation of somatic 
cells and germ cells in the testis, I examined markers specific for Sertoli cells (SOX9), germ 
cells (TRA98) (121), steroidogenic Leydig cells (HSD3b), and proliferation marker Ki67 (Fig. 16). 
No significant differences were observed in KO testis at P0 compared to the control. At P2, the 
numbers of testis cords in the KO testis was decreased (Fig. 16A). I also observed a decrease 
in the number of proliferating Sertoli cells inside the testis cords (Fig. 16B and Fig. 17). At P5, 
the KO testes lost almost all the testis cord structures and only few cords were present. Dicer1 
depletion affected not only testis cords but also Leydig cells in the interstitium. At P2, most of 
the HSD3b-positive Leydig cells disappeared and no Leydig cells were found at P5 (Fig. 16B). It 
is known that Leydig cells at this stage are mitotically inactive ((122, 123) and Fig. 16B); 
therefore, the decrease in Leydig cell number was probably not the result of proliferation 
problems.  
To examine whether the degeneration of the KO testis results from increased cell death, I 
performed immunofluorescence for cleaved caspase-3 (CASP3), a marker for apoptosis. No 
CASP3-positive cells were found in the control testes during development (Fig. 18A). In contrast, 
the KO testes had significant numbers of CASP3-positive cells starting at 18.5 dpc and 
becoming prominent at P0 and P2 (Fig. 18A). By double staining with the germ cell marker 
TRA98 or the basement membrane marker laminin, I found that most of the CASP3-positive 
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cells in P0 knockout testes belonged to TRA98-negative Sertoli cells inside the testis cords and 
cells in the interstitium (Fig. 18B and D). At P2, CASP3 staining was observed in both TRA98-
positive germ cells and TRA98-negative Sertoli cells inside the testis cords (Fig. 18C) and only 
few CASP3-positive cells were found in the interstitium (Fig. 18E).   
 
3.3.3 Ablation of Dicer1 does not disturb fetal and neonatal development of the ovary 
Target gene deletion mediated by Sf1/Cre transgene occurs in all SF1-positive tissues, 
including the ovary (94). In our lab, the identical Sf1/Cre transgenic mouse line was used 
successfully to inactivate beta-catenin in the fetal ovary (120). I analyzed the Dicer1 knockout 
ovary mediated by the same Sf1/Cre at fetal stages and up to P5 and found no differences in 
morphology and marker expression between control and KO ovaries (Fig. 19). At P5, the size, 
staining patterns of cell specific markers (HSD3b and SF1 for somatic cells and TRA98 for germ 
cells), and markers for proliferation (Ki67) and apoptosis (CASP3) were indistinguishable 
between WT and KO ovary (Fig. 19). 
 
3.4 DISCUSSION 
In the Sf1/Cre-mediated Dicer1 knockout mice, adrenal cortical cells are the first SF1-
positive population that undergoes apoptosis at fetal stages, followed by testicular Leydig cells 
and Sertoli cells, respectively. Loss of somatic cells in the testes eventually leads to germ cells 
loss in the Dicer1 KO testis. Adrenal degeneration in the Dicer1 KO starts between 16.5-18.5 
dpc and by the time of birth, adrenal cortical cells are almost completely abolished. In the testis, 
however, degeneration becomes apparent only after birth and progresses rapidly. By P5, almost 
all the functional structures and cell types in the testis are no longer present. Intriguingly, 
ovaries, which derive from the same SF1-positive primordium as adrenal and testis, show no 
morphological and cellular changes from fetal stages to P5 in response to the loss of Dicer1. 
Increased apoptosis has been reported in tissues that lack Dicer1 (67-70). Increased cell death 
in testes and adrenals in my study further suggests that Dicer1 and microRNAs processed by 
DICER play a universal role in maintaining cell survival. 
In the adrenal, the cortical cells are derived from at least two sources: 1) the SF1-positive 
adrenal primordium, which forms the foundation of the organ and 2) SF1-negative capsular cells, 
which contribute to further growth of the adrenocortex (5, 124-126). It is known that loss of Sf1 
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leads to apoptosis of adrenal cortical cells and adrenal dysgenesis at birth (3, 127). Loss of 
Dicer1 in the SF1-positive cortical cells also leads to apoptosis of the cortex; however, the 
degeneration process occurs much later than that in the case of Sf1 KO. It is possible that 
Dicer-regulated miRNAs control genes that are critical for cortical cells survival, such as Sf1. 
However, in the Dicer1 KO adrenal, SF1 is still present in the remaining cortical cells. Depletion 
or mutation of Cited2, Wt1, and Pbx1 also resulted in prenatal adrenal dysgenesis in mouse 
embryos (87, 128, 129). Involvement of Dicer and miRNAs in regulation of these genes in 
adrenal development remains to be determined.   
Adrenocortical degeneration was also reported in β-catenin conditional KO mice (74). β-
catenin deficiency mediated by the same Sf1/Cre resulted in underdeveloped adrenal cortex; 
however, no apoptosis was found at fetal stages. These data suggest that regulation of adrenal 
development via β-catenin is probably independent from DICER-regulated miRNA machinery or 
vice versa.  
Dicer and other components of the miRNA-mediated interference machinery are present in 
the testis, including germ cells and Sertoli cells (130-132) (133). Germ cell-specific Dicer1 
knockout mice were generated using the TNAP/Cre that is active in the primordial germ cells 
(72, 73). Loss of Dicer1 in germ cells led to defects in proliferation and differentiation of 
spermatogonia and abnormal morphology and motility of sperm (72, 73). Sertoli cell-specific 
Dicer1 KO mice was generated using the anti-Müllerian hormone Cre (Amh-cre) line that targets 
Sertoli cells starting at ~15.5 dpc (70). Loss of Dicer1 in Sertoli cells resulted in impaired 
spermatogenic waves and completely absence of spermatozoa. In addition, increased Sertoli 
cell apoptosis was found at P5 and germ cells underwent apoptosis at P15, eventually leading 
to complete testis degeneration at P180. In my Sf1/Cre-mediated Dicer1 KO model, I targeted 
both Sertoli cells and Leydig cells at earlier stage (10-11 dpc). I observed testis degeneration 
earlier and more dramatic than the Sertoli cell Dicer1 KO. In my model, almost all testicular 
structures and cell types were absent at P5. As expected, both Sertoli and Leydig cell 
populations underwent apoptosis albeit with different time frames (the number of Leydig cells 
decreases first, followed by Sertoli cells). Although male germ cells are negative for SF1, their 
survival was affected in the somatic cell-specific Dicer1 KO testis. This is expected as Sertoli 
cells are known to provide structural supports and differentiation cues to support 
spermatogenesis (134). Although Leydig cells were also affected in my model, I do not believe 
that their demise is responsible for the germ cell loss phenotypes based on the fact that male 
germ cells are not known to respond to androgens, the major product of Leydig cells. In the 
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SF1-mediated Dicer KO testis, the remaining Sertoli cells calling into question the “survival 
factor” theory of Dicer and presumably miRNA. However, the gradual appearance of apoptosis 
in mutant Sertoli cells may lead to some Sertoli cells that survive up to D5. It draws my attention 
that a portion of mutant testis contains a lot of spindle shape testicular cells (not germ cells, 
Sertoli cells nor Leydig cells) at D5. Based on the shape of these cells, the remaining cells are 
probably interstitial connective cells. Due to the fact that Sertoli and Leydig cells are terminally 
differentiated cell types, the remaining cells should not be cells derive from Sertoli and Leydig 
cells. Furthermore, the transdifferentiation of testicular cells into ovarian cells has never been 
reported.  
Dicer1 is also expressed in the female reproductive tract and the ovary, including oocytes, 
theca cells and granulosa cells (135-138). Many miRNAs are synthesized in ovaries at different 
stages of folliculogenesis (139-141). It has been reported that morphogenesis and function of 
the female reproductive tract were affected in the absence of Dicer1 (138). To study the in vivo 
role of Dicer1 in the mouse ovary, granulosa cell specific Dicer1 KO mice were generated by 
using Amhr2/Cre, which is expressed, in granulosa cells of preantral and antral follicles (76, 
142-144). Two different Dicer1-floxed strains were used and both showed that loss of Dicer1 in 
granulosa cells resulted in decreased ovulation rate, trapped oocytes in luteinized follicles and 
increased numbers of atretic follicles (71, 74, 75). Fertilized oocytes collected from granulosa 
cell-specific Dicer1 KO females decreased the ability to progress to the two-cell stage (75). I 
was not able to examine the consequence of loss of Dicer1 on folliculogenesis due to death of 
Dicer1 KO animals at P5 as a result of adrenal cortex degeneration. However at least at P5, 
Dicer1 KO ovaries show no signs of degeneration.  
Based on findings from our lab and others, Sf1/Cre-medicated gene deletion occurs in 
adrenals and gonads at 10-11 dpc. In the Sf1/Cre-mediated Dicer1 KO embryos, defects in 
adrenals and testes did not become apparent until 18.5 dpc and P0, respectively, and the 
ovaries were not affected. The extended delay between deletion of Dicer and the appearance of 
phenotypes suggests that Dicer and/or microRNAs might have a substantial half-life (70). It also 
raises the possibilities that (i) these organs have different turn-over rate of Dicer and/or Dicer-
induced microRNAs, (ii) these three organs have different thresholds of tolerance toward the 
loss of Dicer1 and microRNAs, and/or (iii) Dicer and microRNAs play tissue-specific roles 
among these three organs. In the Sertoli cell-specific Dicer1 KO testis, the significant 
alternations in gene expression have already occurred at the time when structural changes are 
not yet detectable. The future experiments of this project will be testing these three possibilities 
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by performing a time course analysis of changes in Dicer1 mRNA, Dicer protein and microRNAs 
in these three tissues after Dicer1 ablation.  
 
3.5 MATERIALS AND METHODS 
3.5.1 Generation of conditional Dicer1 knockout mice 
Conditional Dicer1 knockout mice were generated by crossing Sf-1/Cre transgenic mice (94) 
with Dicer1f/f mice (Dicer1tm1Bdh, obtained from the Jackson Laboratory) (67, 68, 72, 119). The 
genetic background of these mice was mixed C57BL/6J and SV129. Female and male mice 
were paired together and checked for the presence of a vaginal plug the next morning. The day 
when the vaginal plug was detected was considered 0.5 day post coitum or dpc. Samples were 
collected at 14.5 dpc, 16.5 dpc, 18.5 dpc, birth (P0), postnatal day 2 and 5 (P2 and P5). The 
genotype was determined by polymerase chain reaction (PCR) of tail DNA (54, 68). All 
procedures described were reviewed and approved by the Institutional Animal Care and Use 
Committee at University of Illinois and were performed in accordance with the Guiding 
Principles for the Care and Use of Laboratory Animals. All experiments were performed on at 
least three animals for each genotype. 
 
3.5.2 Immunofluorescence 
The specimens were fixed in 4% paraformaldehyde/phosphate-buffered saline (PBS) at 4°C 
overnight, and embedded in paraffin following standard procedures for sectioning. For 
immunofluorescence analysis, paraffin embedded sections were dewaxed and rehydrated in a 
series of alcohol/PBS gradient. The endogenous peroxidase activity was blocked by 3% H2O2 in 
methanol for 8 minutes and rinsed with PBS 3 times for 5 minutes each. Slides were pretreated 
in 0.1mM citrate acid for 20 minutes in the microwave. After preincubating with 1.5% normal 
donkey serum in PBS for 30 minutes, sections were incubated with either anti-SF1, anti-CYP21 
(1:1000, kindly provided by Dr. B-c Chung, Academia Sinica, Taiwan),  anti-TH (1:1000, 
Millipore, Billerica, MA, USA), anti-3βHSD, anti-SOX9 (1:1000, kindly provided by Dr. K. 
Morohashi, National Institutes of Natural Sciences, Japan.), anti-Laminin (1:500, Sigma-Aldrich, 
St. Louis, MO, USA), anti-TRA98 (1: 1000 kindly provided by Dr. H. Tanaka, Osaka University, 
Japan), anti-cleaved Caspase-3 (1:500, Cell Signaling, Danvers, MA, USA) or anti-Ki-67 
antibody (1:1000, BD Biosciences, San Jose, CA, USA) in PBST containing 1.5% normal 
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donkey serum at 4°C overnight. After rinsing with PBST, sections were incubated with 
secondary antibody for 30 minutes and processed for signal detection according to the 
manufacturer’s protocol (TSA kit, PerkinElmer, Waltham, MA, USA). For double-fluorescent 
staining of anti-cleaved Caspase-3 with other antibodies, staining of cleaved Caspase-3 were 
performed first as described above, samples then were double stained for the other antibodies 
using different fluorescent-label secondary antibodies. For other double-fluorescent staining, 
tissue sections were treated with two different primary antibodies generated from different 
species, followed by appropriate secondary antibodies. At least three animals were examined 
for each genotype. 
 
3.5.3 TUNEL assay 
TUNEL assay was performed on 5μm paraffin sections using Roche’s TUNEL assay kit (Roche 


















Figure 12: Effects of Dicer1 ablation on adrenal development. Adrenal glands from control 
(CT) or SF1/Cre;Dicer1loxP/loxP (KO) embryos (16.5 and 18.5 dpc), newborns (P0), and day 5 
neonates (P5) were collected for (A) gross morphological analysis, (B) immunofluorescence for 
SF1 (magenta), TH (green), and DAPI (blue), and (C) immunofluorescence for Ki-67 (green), 
HSD3b (magenta), and DAPI (blue). Higher magnification (2X of the original figure) of the 












Figure 13: Effects of Dicer1 ablation on adrenal apoptosis. TUNEL assay was performed on 
sections of adrenals at 14.5 dpc, 16.5 dpc, 18.5 dpc, P0, and P5. Green nuclear staining 
represents positive signals for fragmented DNA and blue staining was the DAPI nuclear 
counterstain. Immunofluorescence for CYP21 (magenta) was also performed on adrenal 
sections to label the adrenal cortex. Higher magnification (4X of the original figure) of the 


















Figure 14: Effects of Dicer1 ablation on fetal testis development. Testes from control (CT) 
or SF1/Cre;Dicer1loxP/loxP (KO) embryos at 16.5 dpc and 18.5 dpc were collected for 













Figure 15: Effects of Dicer1 ablation on neonatal testis development. Testes from control 
(WT) or SF1/Cre;Dicer1loxP/loxP (KO) newborns (P0), Day 2 (P2), and Day 5 (P5) neonates were 
collected for (A) Gross morphological analysis and (B) immunofluorescence for laminin (green) 





Figure 16: Effects of Dicer1 ablation on differentiation of germ cells, Sertoli cells, and 
Leydig cells in the testis. Testes from control (WT) or SF1/Cre;Dicer1loxP/loxP (KO) newborns 
(P0), Day 2 (P2), and Day 5 (P5) neonates were collected for (A) immunofluorescence for germ 
cell nuclear marker TRA98 (magenta), Sertoli cell marker SOX9 (green) and DAPI counterstain 
(blue) and (B) immunofluorescence for Leydig cell marker HSD3b (magenta), proliferation 
marker Ki67 (green), and DAPI (blue). Higher magnification (2X of the original figure) of the 





Figure 17: Effects of Dicer1 ablation on proliferation in the testis. Testes from P2 and P5 
control (CT) or SF1/Cre;Dicer1loxP/loxP (KO) neonate were examined by immunofluorescence for 





Figure 18: Effects of Dicer1 ablation on apoptosis in the testis. (A) Immunofluorescence for 
cleaved Caspase3 (CASP3) was performed on sections of testes at 18.5 dpc, P0, P2, and P5. 
Green nuclear staining represented positive signals for apoptotic cells and blue staining was the 
DAPI nuclear counterstain. Double staining of CASP3 (green) and TRA98 or laminin (magenta) 
was performed on testes from P0 (B and D) and P2 (C and E) KO testes. Dotted lines mark the 
testis cords. Arrowhead= apoptotic cells outside the testis cord. Arrow= apoptotic germ cells. 





Figure 19: Effects of Dicer1 ablation on ovary development. Ovaries from control (CT) or 
SF1/Cre;Dicer1loxP/loxP (KO) Day 5 neonate (P5) were collected for (A) immunofluorescence for 
Ki67 (green) and HSD3b (magenta), (B) immunofluorescence for TRA98 (green) and SF1 
(magenta), (C) immunofluorescence for CASP3 (green) and HSD3b (magenta). All sections 














CHAPTER 4: INVESTIGATING THE ROLE OF ADRENAL CORTEX IN ORGANIZATION AND 
DIFFERENTIATION OF THE ADRENAL MEDULLA IN MICE 
4.1 ABSTRACT 
The goal of this study was to investigate whether abnormal development of the adrenal cortex 
affects the differentiation of the adrenal medulla in mice. It is known that catecholamine 
synthesis, the major function of adrenal medulla, is under the control of glucocorticoids, one of 
the steroids from the adrenal cortex. To further investigate how adrenal cortex controls medulla 
development and function, I analyzed four different genetic models that develop various defects 
in the adrenal cortex. By using the Sf1/Cre mouse line that conditionally inactivates/activates 
genes in the SF1-positive cells of the fetal adrenal cortex, I produced 1) cortex dysgenesis 
(Sf1/Cre-mediated beta-catenin knockout), 2) cortex hypoplasia (Sf1/Cre-mediated Sonic 
hedgehog or Shh knockout), 3) progressive degeneration of fetal adrenal cortex (Sf1/Cre-
mediated Dicer1 knockout) and 4) adrenal disorganization (Sf1/Cre-mediated beta-catenin 
activation). I found that adrenal medulla formed in all four models regardless the defects in 
adrenal cortex development. The expression of phenylethanolamine N-methyltransferase 
(PNMT), a key enzyme of catecholamine synthesis, remained unaffected in all models, 
suggesting that the numbers of cortical cells do not affect the differentiation of neural crest cells, 
which are precursors of the adrenal medulla. However, the beta-catenin knockout mice (cortex 
dysgenesis) as well as the beta-catenin activation mice (adrenal disorganization) both 
developed misplaced medulla outside of adrenal proper, indicating that beta-catenin pathway in 




In the adrenal, the cortex and medulla develop from two distinct origins: the coelomic 
epithelium for the adrenal cortex and the neural crest for the medulla. Cells in the coelomic 
epithelium proliferate and give rise to the adrenogonadal primordium, the primitive organs for 
adrenal and gonads. The adrenogonadal primordium starts to express SF1 at approximately 9.0 
dpc in the mouse embryos (19). SF1 marks the steroidogenic precursors, which later become 
adrenal cortex and somatic cells in the future gonads. The adrenogonadal primordium 
separates into adrenal and gonads between 11.5-12.5 dpc. Immediately after the separation, 
neural crest cells migrate into the growing adrenal and form the medulla. Around 14.5 dpc, the 
adrenal is encapsulated by a layer of mesenchyme-derived tissue and distinct cortex and 
medulla are established at 16.5 dpc (118). The differentiation of functional zones (cortical 
zonation, including zona glomerulosa, zona fesciculata and zona reticularis) and medulla 
formation are nearly completed by birth. Defects in prenatal adrenal development often lead to 
adrenal hypoplasia or dysplasia, which is life threatening. Mutations of genes such as Sf1 have 
been linked to adrenal hypoplasia or dysplasia (128, 145). Other signaling pathway including 
Sonic hedgehog and WNT are also implicated in adrenal agenesis (128, 146). In mice, most of 
the adrenal structure is established during the fetal stage and becomes functional at birth. 
One of the major functions of adrenal gland is to produce catecholamines and 
glucocorticoids in response to stress. Catecholamine, synthesized by the adrenal medulla, is 
responsible for blood pressure and blood flow regulation whereas glucocorticoid produced by 
the cortex controls energy homeostasis. Glucocorticoid also has a stimulatory effect on 
medullary catecholamine synthesis. PNMT, the enzyme that converts norepinepherine to 
epinephrine, is activated by glucocorticoid in vitro and in vivo (147, 148). In hypophysectomized 
rats, the expression of PNMT in the adrenal medulla was significantly reduced (149, 150). The 
reduced PNMT expressed was restored by ACTH replacement or high dose of dexamethasone 
treatment, indicating steroids from the adjacent cortex are the major stimulator of PNMT 
expression(149). Based on the histological arrangement of medulla and cortex, steroids from 
the cortex possibly regulates PNMT production in the medulla by either a paracrine mechanism 
or through the local vascular system (151). Despite of this particular aspect of the medulla 




In this chapter, I examined whether development of the adrenal medulla is affected in 
the adrenal that shows different types of defects in the cortex, including cortex dysgenesis 
(Sf1/Cre-mediated β-catenin knockout), cortex hypoplasia (Sf1/Cre-mediated Shh knockout, as 
shown in Chapter 2), mice with progressive degeneration of fetal adrenal cortex (Sf1/Cre-
mediated Dicer1 knockout, as shown in Chapter 3), and mice with adrenal disorganization 
(Sf1/Cre-mediated β-catenin activation). 
 
4.3 RESULTS 
4.3.1 Shh KO adrenal is composed of a hypoplastic cortex with a well differentiated 
chromaffinergic medulla 
Due to the absence of SHH ligands from the cortex, proliferation of the capsule was 
decreased, leading to a hypoplastic cortex in the Shh KO mice (Chapter 2 and Fig. 20G, H, & I). 
The medulla was present in the adrenal of the Shh KO mice (Chapter 2). To further study 
whether the cells in the hypoplastic adrenal are fully differentiated and remain functional in adult 
Shh KO adrenal, I used double immunohistochemistry to examine the expression of PNMT and 
tyrosine hydroxylase (TH), markers for neural crest origin cells (152). Chromaffin reaction was 
also used to detect the chemical activity of catecholamine synthesized in the medulla. In control 
adrenals from 16.5 dpc to D21, the HSD3b-positive adrenal cortex and the TH-positive medulla 
expanded over time (Fig. 20A-F). However in the Shh KO mice, only the TH-positive medulla 
population increase over time but the growth of adrenal cortex was reduced (Fig. 20G-I). Due to 
the decreased number of adrenal cortical cells, adrenal medulla was not fully surrounded by the 
cortex. In the 30 weeks-old KO adrenal, part of the adrenal medulla was directly covered by the 
adrenal capsule rather than the cortex (Fig. 21A-F). Similar to the control adrenal, most of the 
TH-positive cells produced PNMT in the KO adrenal (Fig. 21A-F). To test whether the under-
developed cortex has a long-term impact on medulla functions, I examined the catecholamine 
activity using chromaffin reaction in the adrenals of aging 98-weeks old KO mice. The positive 
chromaffin reaction in the 98-weeks old adrenal indicates that the hypoplastic adrenal cortex in 
the Shh KO adrenal did not affect the maintenance of a functional medulla (Fig. 21G-H).  
 
4.3.2 Progressive degeneration of adrenal cortex in Dicer1 KO mice does not affect 
medulla cell differentiation 
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In the Dicer1 KO mice, the increased apoptosis in the cortex resulted in progressive 
degeneration of adrenal cortex (Chapter 3). I therefore used this model to test whether 
progressive degeneration of adrenal cortex has any impacts on medulla differentiation. 
Immunohistochemistry results showed that Dicer1 KO mice developed and maintain their 
medulla (TH-positive cells) from E16.5 to D5 after birth in spite of a degenerating cortex 
(HSD3b-positive in Fig. 20J-M). To further study whether the degeneration of adrenal cortex 
affects medullar cells differentiation, double immunohistochemistry was used to examine the 
expression of PNMT and TH in the Dicer1 KO adrenal. At 18.5 dpc, similar to the control 
adrenal, most of the medulla cells in the KO adrenal were positive for both TH and PNMT (Fig. 
22A-F). After birth, PNMT-positive medulla remained in the adrenal underneath the capsule at 
D5 (Fig. 22G-H). Due to the loss of functional cortex, Dicer1 KO mice were not able to survive 
after D5 of age. The expression of PNMT in D5 Dicer1 KO adrenal suggests that the 
progressive loss of adrenal cortex does not result in acute adrenal medulla defect.  
 
4.3.3 Depletion of β-catenin in the SF1-positive cells results in cortex dysgenesis 
whereas ectopic activation of β-catenin in the SF1-positive cells causes cortex-medulla 
disorganization 
Both Shh KO and Dicer1 KO mice formed normal adrenal cortex at early stages and the 
cortical defects did not became apparent at or after 16.5 dpc. Therefore these two models are 
not suitable to study the potential interaction between cortical cells and medulla cells at early 
developmental stages. I and others had found that deletion of β-catenin in the cortical layer led 
to severe adrenal cortical dysgenesis before or at 16.5 dpc (Fig. 20N-P). The size of adrenals in 
the β-catenin conditional KO animals (see Appendix B) was reduced to 5-10% of the size of the 
control littermates at 16.5dpc. By using immunohistochemistry for HSD3b to detect the adrenal 
cortical cells, I found that the number of cortical cells was dramatically reduced (Fig. 20N-P). 
Not only the was adrenal cortex affected in the β-catenin conditional KO adrenal, the population 
of TH-positive cells was also significantly reduced. The remaining cortex was positive for 
CYP11b1, indicating that it is capable to synthesize corticosterone (Fig. 20Q). 
The loss of β-catenin resulted in reduced proliferation and cortex dysgenesis (74). In 
contrast, ectopic activation of β-catenin in the mouse adrenal cortex induces adrenal 
hyperplasia and promotes adrenal cancer development (153). However, in this particular study 
(153), β-catenin was activated at 14.5 dpc and hyperplastic adrenals were found at the age of 5 
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months old. To activate β-catenin at an early developmental stage, I used the Sf1/Cre, which is 
active as early as at 10 dpc, to induce ectopic activation of the β-catenin pathway. In this model, 
the critical phosphorylation sites of β-catenin in the third exon are removed, preventing β-
catenin from degradation and leading to constitutively active β-catenin signaling. Interestingly, 
activation of β-catenin by Sf1/Cre did not result in adrenal hyperplasia at early stages. Instead, 
the size of adrenal in the Sf1-mediated β-catenin activation animals was reduced at 16.5 dpc 
(Fig. 20R). At all stages I have examined, the dysplastic adrenal contained HSD3b-positive 
cortical cells with scattered TH-positive medulla cells (Fig. 20R-V). Although the mutant adrenal 
was small at embryonic stages, the adrenal cortex progressively grew during development. At 
D21, the size of the β-catenin activation adrenal was 50% of the control littermates. Medulla did 
not centralized in the middle of the adrenal at all stages.    
 
4.3.4 Depletion or activation of β-catenin does not affect medulla differentiation 
The striking defect of the adrenal cortex in the β-catenin mutants prompted me to 
examine whether the medulla differentiates properly. In the control adrenal, PNMT and TH 
double-positive medulla cells accumulated centripetally in the adrenal and were surrounded by 
adrenal cortical cells (Fig. 23A, C, & E). In the β-catenin conditional KO adrenal, clusters of TH 
and PNMT double positive chromaffin cells were present and attached to the remaining cortical 
cells (Fig. 23B, D, & F). On the other hand in the adrenal with ectopic activation of β-catenin in 
the cortex, TH-positive cells were not located in the center of the adrenal; instead, the medulla 
cells were separated into clusters and scattered throughout the adrenal cortex (Fig. 24A). The 
scattered TH-positive medulla cells were also PNMT-positive (Fig. 24B). Some PNMT-positive 
clusters were found right underneath the capsule. The result of chromaffin reaction further 
indicates that these medulla clusters produced catecholamine (Fig. 24C & D). Positive of PNMT 
expression and chromaffin reaction of the scattered medulla cells in the β-catenin activation 
adrenal suggests that medulla cells were able to differentiate even though a normal medulla 
proper is not formed.    
 
4.4 DISCUSSION 
In this study, I used Sf1/Cre to generate models with various defects in the adrenal 
cortex. Disruption of Shh or Dicer1 resulted in hypoplastic or degenerated adrenal cortex. β-
catenin KO caused adrenal cortex dysgenesis. The β-catenin activation adrenal developed 
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disorganized cortex-medulla structure. However, in all models, the differentiation of the medulla 
remained grossly intact with proper expression of TH and PNMT. Although these models create 
cortical defects through different mechanism (reduced proliferation or increased apoptosis), they 
all show one similar histological phenotype of the medulla: the adrenal medulla is not fully 
surrounded by adrenal cortex at some developing stages. Thus, these mutant mice serve as 
models for studying the correlation/interaction of cortex and medulla during adrenal 
development. 
Differentiation of the adrenal medulla, specifically the production of PNMT, requires a 
steroidogenic cortex. PNMT apparently is under the control of glucocorticoids from the cortex 
based on the observation that mice lacking ability to produce or respond to glucocorticoids such 
as Cyp21 knockout, CRHR1 (corticotropin-releasing hormone receptor) knockout, Sf1 
heterozygous and GR (glucocorticoids receptor) knockout, had decreased or absent PNMT 
expression in the medulla (106-108, 154). Glucocorticoid responsive element is found upstream 
of Pnmt gene and is required for glucocorticoid induced PNMT expression (155). In the 
hypophysectomized rats, PNMT expression in the medulla was lost as a result of disruption of 
hypothalamic-pituitary-adrenal axis (149, 150). PNMT expression in the medulla was restored in 
this model when high doses of glucocorticoids were given (149). Moreover, low dose of ACTH 
replacement, which induced the endogenous glucocorticoids synthesis, also restored PNMT 
expression in the hypophysectomized rat. These data suggest that PNMT expression in medulla 
requires a relatively high level of glucocorticoid, which comes from the surrounding cortex. 
 The hypoplastic cortex model (β-catenin conditional KO mice), had a disorganized 
cortex-medulla structure with hypoplastic cortical population but still had relatively normal PNMT 
expression in the medulla. The hypoplastic adrenal that could not synthesize and secrete 
sufficient steroids for life maintenance may be one of the causes that lead to neonatal death of 
the β-catenin conditional KO mice. However, the affected cortex apparently produce enough of 
glucocorticoid locally to support medulla differentiation and function. This finding supports the 
idea that the locally produced glucocorticoid is sufficient for medulla PNMT expression.   
In the adrenal, the blood supply enters from the cortex and flows inward.  Cortical 
capillaries run through all three zones of cortex and then drain into the medulla vein (156, 157). 
It is proposed that the glucocorticoid from the cortex were collected in the blood and go through 
the medulla. The glucocorticoid reaches medulla before entering the general circulation. The 
high concentration of glucocorticoid in the local blood supply therefore induces PNMT 
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expression in the medulla. The histological structure of blood vessels in the adrenal explains 
how could endocrine hormones such as glucocorticoid elicit their function locally. However, 
results from the four models in this Chapter challenge this “endocrine” theory of the stimulation 
of PNMT expression. In the β-catenin KO adrenal, PNMT-positive medulla sit beside the cortex 
and was not covered by the cortex. In the aged Shh KO adrenal, part of the PNMT-positive 
medulla was found directly underneath the capsule. In the β-catenin activation adrenal, medulla 
cells were not formed centripetally. Although the direction of the blood flow in the adrenal of 
these models has not been analyzed, the finding of PNMT-positive cells located directly 
underneath the capsule indicates that the de novo synthesized glucocorticoid may elicit its 
function on PNMT expression through paracrine signaling.       
Other than medulla development, one unique phenotype was observed in two of these 
models. Both KO and activation of β-catenin models result in adrenal cortex dysgenesis at 16.5 
dpc. The similar phenotype of loss- or gain-of-function of β-catenin suggests a properly 
balanced β-catenin activity in the SF1-positive cortical cells is critical for early adrenal 
development. Sf1 is essential for formation of the adrenal cortex development during early 
stages. Inactivation of Sf1 leads to loss of adrenal at birth which is associated with decrease 
proliferation at early stages (74). Sf1 haploinsufficiency also impaired adrenal development and 
caused blunted compensatory cortex proliferation, indicating the importance of dosage of Sf1 
genes in adrenal cortical cell proliferation and survival (109, 145). The synergic effect of β-
catenin and SF1 on activation of α-inhibin promoter suggests that β-catenin and SF1 may 
regulate crucial target genes controlling cell proliferation through similar signaling cascade (158). 
It is also possible that β-catenin and SF1 may have direct correlation in terms of expression. 
 
4.5 MATERIALS AND METHODS 
4.5.1 Generation of the β-Catenin conditional KO mice 
Mice carrying the floxed β-catenin allele (Ctnnb1tm2kem) were obtained from the Jackson 
Laboratory (Bar Harbor, ME, USA). The Ctnnb1+/- mice (generated by crossing Ctnnb1tm2kem with 
EIIaCre mice) was mated with Sf1/Cre transgenic mice (the transgene is located on 
chromosome 2, generated by the Dr. Keith L. Parker lab) to obtain the Sf1/Cre; Ctnnb1+/- mouse 
line. β-Catenin conditional knockout mice will be then generated by mating Sf1/Cre; Ctnnb1+/- 




GCATTACCGGTCGATGCAACGAGTGATGAG-3' for SF1/Cre genotyping, 5'-
AATCACAGGGACTTCCATACCAG-3' and 5'-GCCCAGCCTTAGCCCAACT-3' for Ctnnb null 
allele and 5'-AAGGTAGAGTGATGAAAGTTGTT-3' and 5'-CACCATTGTCCTCTGTCTATTC-3' 
for Ctnnb1 wild-type and floxed alleles. 
4.5.2 Immunohistochemistry 
Detailed method is indicated in Chapter 2. In short, the specimens were fixed in 4% 
paraformaldehyde/phosphate-buffered saline (PBS) at 4°C overnight, and embedded in paraffin 
following standard procedures for sectioning. Paraffin embedded sections were dewaxed and 
rehydrated in a series of alcohol/PBS gradient. The endogenous peroxidase activity was 
blocked by 3% H2O2 in methanol for 8 minutes and rinsed with PBS 3 times for 5 minutes each. 
Slides were pretreated in 0.1mM citrate acid for 20 minutes in the microwave. The primary 
antibodies used were anti-HSD3b (1:1000, kindly provided by Dr.), anti-TH (1:1000, Millipore, 
Billerica, MA, USA), anti-PNMT (1:1000, Millipore). All experiments were performed on at least 
three animals for each genotype 
4.5.3 Chromaffin reaction 
Adrenals were fixed in Muller’s Fluid (0.1M K2Cr2O7, 30mM Na2SO4·10H2O) in 4% PFA for 48 
hours and washed in running water overnight. For sections, stained tissues were embedded in 


























































































































































































Figure 21: Effects of cortical hypoplasia on medulla cell functions in the adrenal. 
Fluorescent immunohistochemistry for TH (A & B) and PNMT (C & D) was performed on 
sections of 30 weeks old control (CT) and Shh conditional KO adrenals. (E) and (F) are merged 
images of TH and PNMT. Chromaffin reaction was performed on 98 weeks old adrenals (G & H). 











Figure 22: Effects of progressive degeneration of cortex on medulla cell functions in the 
adrenal. Fluorescent immunohistochemistry for TH (A & B) and PNMT (C & D) was performed 
on sections of control and  Dicer1 conditional KO adrenals at E18.5. (G) and (H) are merged 
images of TH and PNMT. Fluorescent immunohistochemistry for PNMT on D5 adrenals was 







Figure 23: Effects of cortex dysgenesis on medulla cell function in the adrenal. 
Fluorescent immunohistochemistry for TH (A & B) and PNMT (C & D) was performed on 
sections of β-catenin WT and KO adrenals at D1. (E) and (F) are merged images of TH and 











Figure 24: Effects of cortex tumor on medulla cell function in the adrenal. Fluorescent 
immunohistochemistry for TH (A, green) and HSD3b (A, magenta) and PNMT (B) was 
performed on sections of β-catenin activation adrenals at D21. Chromaffin reaction was 







CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS 
Adrenal, testis and ovary are the three major steroidogenic organs. These three organs 
are all derived from the Sf1-positive adrenogonadal promordium. In this thesis, I used Sf1/Cre 
transgenic mice to generate different types of knockout models to study the development of Sf1-
positive cells in mice. My study is specifically focused on (1) the contribution of adrenal capsular 
cells to the Sf1-positive cortical cells; (2) the maintenance of Sf1-positive cells; and (3) the 
interaction between Sf1-positive adrenal cortical cells and adrenal medulla cells (Figure 25).  
In the fetal mouse adrenal, Shh is the only Hh ligand present and its expression is 
restricted to SF1-positive adrenocortical cells underneath the adrenal capsule (7, 44). On the 
other hand, Ptch1, Gli1 and Gli2 expression are found in the adrenal capsule, which is negative 
for SF1 (125, 126, 146). I and others developed a conditional knockout model that Shh is 
inactivated specifically in the SF1- positive adrenocortical cells (125, 126, 146). Loss of Shh in 
the SF1-positive cells leads to severely stunted adrenal cortex and hypoplasia of the SF1-
negative/Ptch1-positive adrenal capsule. Shh derived from the SF1-positive adrenocortical cells 
apparently controls the expansion of progenitor cells in the capsule. This is based on the fact 
that the thickness of and cell numbers in the capsule are significantly reduced in the Shh 
knockout adrenal. Despite of significant underdevelopment, the Shh conditional knockout 
adrenocortex undergo proper zonation, indicating that Shh is dispensable for differentiation of 
adrenocortex. By using Smo activation model, I found that once the capsular cells differentiated 
into cortical cells, they are refractory to Hh signaling. My findings provide genetic evidence for 
the existence of stem/progenitor cells in the adrenal. I also demonstrated that Hh signaling 
involves in the growth of these stem/progenitor population. The questions remained to be 
answered are (1) What are the genes/signalings that serve as the gate keepers to maintain the 
stem cell properties of capsular cells; (2) whether adrenal capsular cells in adult mice still have 
the stem/progenitor characteristics; and (3) Do the adrenal capsular cells have the ability to 
differentiate into other types of cells other than adrenocortical cells? 
One key experiment to answer these questions is to isolate capsular cells from mice at 
different stages or further put them in the primary cell culture. Because the Gli1 expression is 
restricted in the capsule, it is possible to isolate capsular cells by cell sorting using LacZ 
antibody or other Gli1 reporter mouse lines. Obtaining a pure population of these Gli1-positive 
cells as well as the primary cell culture of capsular cells will be a powerful tool for the field of 
adrenal research. By examining the gene expression profile of capsular cells or doing ex vivo 
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differentiation/undifferentiation of the primary culture could help us to understand the detailed 
mechanism of the potential stem/progenitor proper of adrenal capsular cells.  
In Chapter 3, I found that the lack of Dicer1 results in apoptosis of cells. In the testis, the 
apoptosis of somatic cell further causes germ cell death. However, depletion of Dicer1 in 
ovarian somatic cells does not cause apoptosis at the same stage. Other study also showed 
that loss of Dicer1 in granulosa cells does not result in universal apoptosis. The tissue specific 
tolerance and the extended delay between deletion of Dicer1 and the appearance of 
phenotypes leave a question of how Dicer1/miRNA interact with other signaling molecules that 
are involved in cell survival. The tissue differences of Dicer/miRNA regulation on apoptosis may 
be an advantage to study the detailed mechanism of miRNA mediated cell death. By comparing 
the miRNA profile of different tissues or same tissues at different stages could highlight the 
candidate miRNAs that correlate with the phenotypes. In the field of veterinary medicine, the 
non-surgical sterilant/technology for use in both male and female pets is still lacking. miRNA 
dependent cell survival might be the potential mechanism that can be applied in the future.  
In the Chapter on the study of adrenal medulla development, I used four different models 
to address the idea that the differentiation of adrenal medulla cells or the expression of medulla 
PNMT does not require a well organized cortex-medulla structure. Other studies have proven 
that the expression of medulla PNMT relies on the de novo synthesized glucocorticoid directly 
coming from the adjacent cortex. Based on the histological structure of adrenal cortex, medulla 
and the blood vessel, it is hypothesized that glucocorticoid, the endocrine hormone, regulates 
medulla PNMT through the classic endocrine mechanism. Although there is no convincing 
method to study the direction of the blood flow in those mutant mouse adrenals, the highly 
colocalized pattern of PNMT and TH-positive medulla cells suggests that glucocorticoid 
stimulates PNMT expression in adrenal medulla cells, no matter where the medulla cells are 
located. The other unknown question in the field is that whether adrenal cortex is required for 
medulla cell survival. To answer this question, the Dicer1 KO mouse, which serves as a model 
of progressive degeneration of adrenal cortex may be used. These mice have well developed 
adrenal medulla at birth but have progressive degenerated adrenal cortex. Through the rescue 
experiment by steroids replacement, Dicer1 KO mice could survive after the stage when the 
adrenal cortex is completely degenerated, making it possible to study the effect of adrenal 












Figure 25: Model of the development and the function of SF1-positive cells in the 
adrenal. The SF1-positive precursor cells in the cortex form the foundation of fetal adrenal. 
These cells produce SHH whereas are negative for downstream Hh components such as Gli1 
and Ptch1. Adrenocortex-derived SHH acts on SF1(-) /Gli1(+) precursor cells in the capsule 
and stimulates their proliferation. The progeny of the adrenal capsular cells migrate inward, 
become positive for SF1, lose expression of Gli1, and then differentiate into adrenocortical 
cells. DICER/miRNAs are required for the maintenance of SF1-positive cortical cells. 
















































































































































































































































































































































































































































































3β-HSD 3β- Hydroxysteroid dehydrogenase 
ACTH adrenacorticotropin 
AVP arginine vasopressin
CAH congenital adrenal hyperplasia 
CNS central nervous system 
CRF corticotrophin-releasing factors 
CRH corticotrophin-releasing hormone 
CRHR1  corticotrophin-releasing hormone receptor type 1 
DHH Desert Hedgehog 
dpc day post coitum 
GR glucocorticoid receptor 
Hh Hedgehog 
HPA hypothalamic-pituitary-adrenal 
HRE Hedgehog responsive elements 
HSD3b 3β- Hydroxysteroid dehydrogenase 
H&E hematoxyline and eosin stain 
KO knockout 
miRNA microRNA 
PBS phosphate-buffered saline 
PNMT phenylethanolamine N-methytransferase 
POMC pro-opiomelanocortin 
RT-PCR reverse transcription-polymerase chain reaction 
SF1 Steroidogenic factor 1 
SHH Sonic Hedgehog 
TH tyrosine hydroxylase  
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APPENDIX B: DEPLETION OF SONIC HEDGEHOG IN SOMATIC CELLS DOES NOT 
AFFECT MOUSE GONAD DEVELOPMENT 
B.1 INTRODUCTION 
In Chapter 2, I presented data from the study of Shh KO adrenal. In this model as a result of the 
Sf1-cre activity, Shh was also depleted in the somatic cells of the gonads. As presented in 
Chapter 1, Hh signaling has been shown to be active in testis and ovary. Sertoli cells in the fetal 
testis (Dhh) and granulosa cells in the adult ovary (Dhh and Ihh) are Hh producing cells which 
are also SF1-positive. By using RT-PCR, I found that Shh is expressed in mouse fetal testes 
and ovaries. I therefore examined whether there are gonadal phenotypes in the Sf1/Cre 
mediated Shh KO mice.  
 
B.2 RESULTS 
Since all the commercial SHH antibodies I have tested do not give a convincing SHH 
expression pattern, I utilized the Shh-CreER model that expresses a tamoxifen-inducible Cre 
recombinase (CreER) that is driven by Shh promoter to obtain the Shh expression pattern. 
Addition of tamoxifen activates the Cre recombinase, which turns on the reporter gene such as 
LacZ. I applied tamoxifen treatments to mice carrying Shh-CreERT2 and ROSA26 LacZ reporter 
genes on postnatal day 14 (or D14) and D15. Mice were sacrificed at D25 and whole mount 
LacZ staining was performed. LacZ staining was positive in epididymis, ovary and uterus but not 
in the testis (Fig. 26). To study the function of Shh from somatic cells in gonads, I used Sf1-Cre 
transgenic mice to generate the conditional Shh KO mice. Using Sf1-Cre, Shh is deleted in all 
Sf1-positve cells at early developmental stages, including Leydig cells, Sertoli cells, theca cells 
and granulosa cells. At D5, D21 and 30 weeks old, Shh KO testis had normal histological 
structure with similar expression pattern of the Leydig cell marker (HSD3b) and the germ cell 
marker (TRA98) (Fig. 27). No increase or decrease of apoptosis was found in the KO testis at 
the age of 30 weeks old (Fig. 29).In female mice at D5, KO ovaries had similar expression 
patterns of steroidogenic cells (HSD3b) and germ cell (TRA98) markers. KO ovaries also had 
normal follicle development at D21 and 30 weeks old (Fig. 28) At D21, apoptosis occurs in 
atresic follicles, both in wild type and KO mice (Fig. 29). To study whether the KO mice are 
fertile, Shh KO male and female mice were housed together and the litter size were counted. 
The litter size of Shh KO male mice cross with KO female mice was similar with wild type mice 




In mammals, three Hh orthologs have been identified: Desert hedgehog (Dhh), Indian hedgehog 
(Ihh), and Sonic hedgehog (Shh). The Hh ligands are produced by the earliest differentiated 
Steroidogenic factor 1 (SF1)-positive cells such as adrenocortical cells in the adrenal, Sertoli 
cells in the testis, and granulosa cells in the adult ovary. These tissue-specific ligands then act 
upon Hh-responding cells located mainly in the mesenchyme, including capsular cells in the 
fetal adrenal, fetal Leydig cells in the testis, and theca cells in the adult ovary. Although these 
three Hh genes have diverse expression patterns and functions, they are thought to induce a 
common signal transduction pathway in the target cells. I investigated the function of Shh in 
adrenals and gonads by producing a conditional knockout model where Shh is inactivated in the 
SF1-positive cells in adrenals and gonads as early as at embryonic day 11.5. Inactivation of Shh 
in the SF1-positive cells affected fetal adrenal growth but yielded no ovarian/testicular 
phenotypes. It was reported that other Hh ligands are present in gonads: Dhh in the testis and 
Ihh and Dhh in the ovary. My results suggest that 1) loss of Shh could be compensated by other 





Figure 26: The expression pattern of Shh in D25 mouse reproductive system. LacZ 
staining was performed on whole mount samples from Shh/CreER; ROSA/LacZ reporter mice. 


































































































































































































































































































































Figure 29: The pattern of apoptosis in ovaries and testes in Shh KO mice. TUNEL assay 














Figure 30: The litter size produced by parents of different genotype combinations. Wild 
type (WT), Shh heterozygous (HT), Shh double floxed (FF) and Shh knockout (KO).*The data of 















APPENDIX C: LOSS OF BETA-CATENIN IN ADRENAL CORTICAL CELLS LEADS TO 
CONGENITAL ADRENAL HYPOPLASIA WITHOUT AFFECTING ADRENAL CHROMAFFIN 
CELLS DIFFERENTIATION 
C.1 Abstract 
Adrenal cortex contains steroidogenic cells, which synthesize and secrete steroids, which 
include glucocorticoids, mineralcorticoids and sex steroids. Glucocorticoids from the adrenal 
cortex play important roles in not only carbohydrate metabolism and energy balance, but also 
catecholamine synthesis in the adrenal medulla. Steroidogenic factor 1 (SF1), an orphan 
nuclear receptor, is critical for adrenal cortex survival and steroidogenesis and disruption of SF1 
leads to adrenal aplasia. β-catenin, a transcription factor involved in the WNT signaling pathway, 
was recently reported that is also linked to adrenal aplasia. In this study, we used the Cre/loxP 
recombination system to conditionally remove β-catenin in the SF1-positive cells in the adrenal 
cortex. In the β-catenin conditional knockout animal, adrenal cortex was severely hypoplastic 
with decreased proliferation.  Although β-catenin conditional knockout adrenal had significant 
fewer cortical cells, the adrenal medulla cells were not affected and differentiated into functional 
epinephrinergic cells. These results indicate that (1) β-catenin is essential for the proliferation 
and expansion of adrenal cortex and (2) differentiation of the adrenal medulla does not require a 








*This Appenix is the manuscript published in Adaptive Medicine. Chen-Che Jeff Huang, Chia-Feng Liu, 
and Humphrey Hung-Chang Yao (2010). Loss of β-Catenin in Adrenal Cortical Cells Leads to Congenital 





In the adrenal, the cortex and medulla develop from two distinct origins: the coelomic 
epithelium for the adrenal cortex and neural crest for the medulla. Cells in the coelomic 
epithelium proliferate and give rise to the adrenogonadal primordium, the primitive organs for 
adrenal and gonads. The adrenogonadal primordium starts to express the orphan nuclear 
receptor Steroidogenic factor1 [Sf1, also known as Nr5a1, Ad4BP, or Ftzf1 (OMIM 184757)] at 
approximately 9.0 days post coitus or dpc in the mouse embryos (19). SF1 marks the 
steroidogenic precursors, which later become adrenal cortex and somatic cells in the future 
gonads. The adrenogonadal primordium separates into adrenal and gonads between 11.5-12.5 
dpc. Immediately after the separation, the neural crest cells migrate into the growing adrenal 
and form medulla. Around 14.5 dpc, the adrenal is encapsulated by a layer of mesenchyme-
derived tissue and distinct cortex and medulla are established at 16.5 dpc (118). Cortical 
zonation and medulla formation are nearly completed by birth. In mouse, most of the adrenal 
structure is established during the fetal stage and becomes functional at birth. Defects in 
prenatal adrenal development often lead to adrenal hypoplasia or dysplasia, which is life 
threatening. Mutations of genes such as Sf1 have been linked to adrenal hypoplasia or 
dysplasia (128, 145). Other signaling pathway including Sonic hedgehog and WNT are also 
implicated in adrenal agenesis (128, 146).  
The canonical WNT signaling pathway is activated by binding of an extracellular 
secreted glycoprotein WNT to the transmembrane receptor frizzled (Fz). In the absence of WNT 
ligands, its intracellular effecter β-catenin is phosphorylated and targeted for degradation by 
ubiquitination (159). When WNTs bind to the Fz receptor, a signaling cascade is induced and 
phosphorylation of β-catenin is inhibited, therefore leading to accumulation of β-catenin in the 
cytoplasm.  β-catenin then is translocated into the nucleus where it regulates expression of 
genes critical for cell proliferation and differentiation (160, 161). Wnt4, one member of the Wnt 
family, is expressed in the developing adrenal. Disruption of Wnt4 in mouse embryos alters 
adrenal function including reduced aldosterone production (89). Recent study also indicates that 
targeted disruption of β-catenin in Sf1-expressing cells results in adrenal hypoplasia due to 
impaired development and maintenance of the adrenal cortex (74). In this manuscript, we 
examined whether differentiation of the adrenal medulla is affected in the adrenal that lacks β-
catenin in the cortex. The adrenal hypoplasia in the β-catenin knockout mice provides us an in 




Traditional β-catenin knockout (KO) mice died at early embryonic stage and showed 
general growth retardation. We therefore developed a conditional knockout model where β-
catenin was inactivated only in the SF1-positve cells to prevent the general defects resulting 
from universal loss of β-catenin. The Cre recombinase driven by the Sf1 promoter (Sf1/Cre) 
became active as early as at 10 dpc to remove the floxed β-catenin from exon 2 through exon 6 
(162). We first examined the adrenal at birth and observed severe adrenal hypoplasia in the β-
catenin conditional KO animals compared to the control (Fig. 31). The size of adrenals in the β-
catenin conditional KO animals was reduced to 5-10% of the size of the control littermates 
(arrows in Fig. 31A and B). By using immunohistochemistry for SF1 to detect the adrenal 
cortical cells, we found that the number of SF1-positive cortical cells was dramatically reduced 
(Fig. 31C-F). The remaining cortex in the β-catenin conditional KO animals was positive for the 
presence of Cyp21 mRNA detected by in situ hybridization, indicating that the remaining SF1-
expressing cortex is steroidogenic (Fig. 31G & H). 
To identify the mechanism of the prenatal adrenal hypoplasia, we compared the number 
of the proliferating cells as well as the thickness of the adrenal capsule in the wild type and β-
catenin conditional KO adrenals. In the wild type adrenal, proliferating cells, marked by 
immunostaining of Ki67, were mainly localized in the outer layer of the cortex underneath the 
capsule (Fig. 32). Proliferating cells were also found in the medulla. However in the β-catenin 
conditional KO adrenal, very few Ki67-positive proliferating cells were present in the remaining 
cortex and only one to two layer of the adrenal capsule remained (Fig. 32A-D). Proliferation of 
cells in the medulla was not significantly affected.    
The striking defect of the adrenal cortex prompted us to examine whether the medulla 
differentiates properly in the β-catenin conditional KO adrenal. By detecting the presence of 
tyrosine hydroxylase (TH), we were able to localize chromaffin cells which form the adrenal 
medulla (Fig. 33). In the wild type adrenal, TH-positive chromaffin cells accumulated 
centripetally in the adrenal and were surrounded by adrenal cortical cells (Fig. 33A). Clusters of 
chromaffin cells, which belonged to the sympathetic ganglia, were also found outside the 
adrenal (arrowheads in Fig. 33). In the β-catenin conditional KO adrenal, clusters of TH-positive 
chromaffin cells were still present and attached to the remaining cortical cells (Fig. 33B). 
Expression of phenylethanolamine N-methyltransferase (PNMT), the enzyme responsible for 
epinephrine synthesis in the adrenal medulla, was also examined. Expression of PNMT the 
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medulla is known to be regulated by glucocorticoids from the cortex. Interestingly, although the 
β-catenin conditional KO adrenal contained few cortical cells, chromaffin cells still differentiated 
into the PNMT-positive epinephrinergic cells (Fig. 33C-D). 
 
C.4 Discussion 
In this study, we used Sf1/Cre to inactivate β-catenin conditionally in adrenal cortical 
cells. Disruption of β-catenin resulted in hypoplastic adrenal cortex with decreased proliferation 
of cortical cells. The β-catenin conditional KO adrenal also developed disorganized cortex-
medulla structure. However, the differentiation of the medulla remained grossly intact with 
proper expression of TH and PNMT. 
The WNT signaling pathway elicits its function through β-catenin in many tissues. In the 
ovary, depletion of Wnt4 or β-catenin shares similar phenotypes including masculinized ovary 
and loss of germ cells (120). Although both Wnt4 and β-catenin are expressed in the developing 
adrenal, loss of β-catenin led to much severe phenotypes in the adrenal than the Wnt4 KO mice. 
In the Wnt4 KO mice, although aldosterone production was decrease, development and 
maintenance of the adrenal cortex were normal in general  (89). β-catenin and its downstream 
signaling could be activated by other Wnts or through Wnt-independent actions (163-165). The 
different adrenal phenotypes between Wnt4 and β-catenin knockout models indicate that other 
Wnt ligands could compensate for the absence of Wnt4 or Wnt4 does not signal via β-catenin. 
Similar to the β-catenin conditional KO mice, inactivation of Sf1 leads to complete 
adrenal absence at birth which associates with decrease proliferation at early stages. Sf1 
haploinsufficiency also impaired adrenal development and caused blunted compensatory cortex 
proliferation, indicating the importance of dosage of Sf1 genes in adrenal cortical cell 
proliferation and survival (109, 145). The synergic effect of β-catenin and SF1 suggests that β-
catenin and SF1 may regulate crucial target genes controlling cell proliferation through similar 
signaling cascade (158).  
Differentiation of the adrenal medulla, specifically the production of PNMT, requires a 
functional cortex. PNMT apparently is under the control of glucocorticoids from the cortex based 
on the observation that mice lacking ability to produce or respond to glucocorticoids such as 
Cyp21 knockout, CRHR1 (corticotropin-releasing hormone receptor) knockout, Sf1 
heterozygous and GR (glucocorticoids receptor) knockout had decreased or absent PNMT 
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expression (106-108, 154). In the hypophysectomized rats, PNMT expression in the medulla 
was lost as a result of disruption of hypothalamic-pituitary-adrenal axis. When glucocorticoids 
replacement was given, only high doses of glucocorticoids were able to restore PNMT in the 
medulla significantly (149). However, PNMT expression was restored by low dose of ACTH 
replacement, which induced the endogenous glucocorticoids synthesis. These data suggest that 
PNMT expression in medulla requires relatively high level of glucocorticoid, which comes from 
the surrounding cortex. In the current study, we showed that the β-catenin conditional KO 
adrenals had a disorganized cortex-medulla structure with hypoplastic cortical population but 
still had relatively normal PNMT expression in the medulla. The neonatal death of the β-catenin 
conditional KO mice indicates that the abnormal adrenal could not synthesize and secrete 
sufficient steroids for life maintenance. However, the glucocorticoids from the affected cortex 
apparently produce enough of glucocorticoids locally to support medulla differentiation and 
function. 
 
C.5 Materials and Methods 
Generation of the β-Catenin conditional KO mice 
Mice carrying the floxed β-catenin allele (Ctnnb1tm2kem) were obtained from the Jackson 
Laboratory (Bar Harbor, ME, USA). The Ctnnb1+/- mice (generated by crossing Ctnnb1tm2kem with 
EIIaCre mice) was mated with Sf1/Cre transgenic mice (the transgene is located on 
chromosome 2, generated by the Dr. Keith L. Parker lab) to obtain the Sf1/Cre; Ctnnb1+/- mouse 
line. β-Catenin conditional knockout mice will be then generated by mating Sf1/Cre; Ctnnb1+/- 
with Ctnnb1f/f mice. Genotyping was performed by PCR analysis using gene-specific primers: 5'-
GAGTGAACGAACCTGGTCGAAATCAGTGCG-3' and 5'-
GCATTACCGGTCGATGCAACGAGTGATGAG-3' for SF1/Cre genotyping, 5'-
AATCACAGGGACTTCCATACCAG-3' and 5'-GCCCAGCCTTAGCCCAACT-3' for Ctnnb null 
allele and 5'-AAGGTAGAGTGATGAAAGTTGTT-3' and 5'-CACCATTGTCCTCTGTCTATTC-3' 
for Ctnnb1 wild-type and floxed alleles. 
Immunohistochemistry 
The specimens were fixed in 4% paraformaldehyde/phosphate-buffered saline (PBS) at 4°C 
overnight, and embedded in paraffin following standard procedures for sectioning. For 
immunohistochemistry analysis, paraffin embedded sections were dewaxed and rehydrated in a 
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series of alcohol/PBS gradient. The endogenous peroxidase activity was blocked by 3% H2O2 in 
methanol for 8 minutes and rinsed with PBS 3 times for 5 minutes each. Slides were pretreated 
in 0.1mM citrate acid for 20 minutes in the microwave. Sections then were blocked, stained, 
visualized by aminoethyl carbazole substrate (AEC), and counter stained with hematoxyline 
(Histostain Broad Spectrum AEC kit, Zymed Laboratories, South San-Francisco, CA, USA) 
according to the manufacturer’s instructions. The primary antibodies used were anti-SF1(1:1000, 
kindly provided by Dr. B-c Chung, Academia Sinica, Taiwan),  anti-TH (1:1000, Millipore, 
Billerica, MA, USA), anti-PNMT (1:1000, Millipore), and anti-Ki-67 antibody (1:1000, BD 
Biosciences, San Jose, CA, USA).  
Whole-mount in situ hybridization 
Tissues were fixed overnight in 4% paraformaldehyde in PBS at 4°C and dehydrated through a 
methanol gradient (25, 50, 70 and 100%) in PTW (0.1% Tween20 in DEPC-PBS). Samples 
were stored in 100% methanol at –20°C. In situ hybridization was processed according to the 
standard non-radioisotopic procedure using digoxigenin-labeled RNA probes. In brief, samples 
were dehydrated through a methanol gradient and then treated with proteinase K (10 mg/ml) at 
37°C for 12 min followed by fixation in 4% paraformaldehyde/0.1% glutaraldehyde immediately 
at room temperature for 20 min. Samples were pre-hybridized in hybridization buffer (5x SSC 
pH 5.0, 50% formamide, 0.1% CHAPS, 0.1% Tween20, 1 mg/ml Yeast tRNA, 50 µg/ml Heparin 
and 5 mM EDTA pH 8.0) at 65°C for 1 h. Then digoxigenin-labeled Cyp21 (provided by Dr. Keith 
L. Parker) RNA probe was added into the solution and samples were rotated in an oven at 65°C 
overnight (12–16 h). Samples were incubated in 20% sheep serum in MABTL blocking solution 
at room temperature for 2 h followed by incubating in alkaline phosphatase-conjugated anti-
digoxigenin at 4°C on shaker overnight. On the third day, after washed in MABTL three times for 
1 h each, samples were incubated in alkaline phosphates substrate in NTMTL (0.1 M NaCl, 0.01 
M Tris–HCl pH 9.5, 0.05 M MgCl2, 1% Tween20, 0.05% Levamisole) for color development. 








Figure 31: Effects of β-catenin ablation on adrenal development. Adrenal glands from wild 
type (WT) or SF1/Cre; Ctnnb1+/- (KO) newborns were collected for (A & B) gross morphology 
analysis and (C & D) immunohistochemistry for SF1. Higher magnification of the SF1-positive 
adrenal cells is shown in (E & F). (G & H) show Cyp21 positive cells by using in situ 
hybridization. Arrow= adrenal and adrenal cortex; kd= kidney; me= medulla. Scale bars 







Figure 32: Effects of β-catenin ablation on cell proliferation in the adrenal  
Immunohistochemistry for proliferation marker Ki67 was performed on sections of (A & C) WT 
and KO (B & D) adrenals at the time of birth. Higher magnification of the proliferating cells is 









Figure 33: Effects of β-catenin ablation on differentiation of adrenal medulla 
Immunohistochemistry for tyrosine hydroxylase (TH, red staining), which detects chromaffin 
cells, was performed on sections of WT (A) and KO (B) adrenals at birth. Immunohistochemistry 
for phenylethanolamine N-methyltransferase (PNMT, dark red staining) was performed on 
adrenal sections to label the epinephrine-synthesized medulla cells. Arrows= adrenal cortex; 
arrowheads= sympathetic ganglia; me= medulla. Scale bars represent 100 μm. 
